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SUMMARY 
The aim of this project was to construct a high level plant expression vector from the 
RNA 3 of cucumber mosaic virus strain Y (CMV Y). The 5'- and 3'-untranslated 
regions (UTRs) of this genome segment were reverse transcribed, cloned and 
sequenced. The chloramphenicol acetyl transferase gene (CAT) was inserted 
between the two UTRs. This artificial viral cDNA (5'cat3') was cloned immediately 
downstream of the cauliflower mosaic virus 35 S promoter at the transcription 
initiation site to make a DNA vector. An RNA vector construct was made by placing 
the 5'cat3' segment under the control of a T7 RNA promoter sequence. In vitro 
transcripts, as well as linearised DNA vector constructs were inoculated onto CMV 
infected plants. Inoculated plants were monitored for CAT expression. No CAT 
could be detected in total protein extracts of inoculated plants. No CAT mRNA could 
be detected in northern blots of total RNA extracted from inoculated plants. The 
vector constructed from the 5' - and 3' -UTR of the RNA 3 of CMV Y did not appear to 
contain all the necessary attributes for a viral expression vector. 
To study the expression of a foreign antigen in tobacco, the L 1 capsid protein of 
human papillomavirus type 16 was cloned into Agrobacterium tumefaciens and used 
to make transgenic Nicotiana tabacum. Kanamycin resistant tobacco plants were 
shown to carry the L 1 capsid gene using PCR screening, but western blots on total 
protein extracts of the transformed plants were indeterminate. Further studies are 
needed to determine whether the antigen is produced and if it is correctly processed. 
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CHAPTER 1 
LITERATURE SURVEY 
"Africa is not poor, but it is, absolutely, impoverished" says Thomas Odhiambo, 
president of the African Academy of Sciences. The per capita gross national 
product (GNP) was a low U.S. $340 in 1992 and the average life expectancy a· 
mere 52 years. This gloomy picture can be altered by a two pronged attack: 
adequate primary health care, especially immunisation against common diseases 
such as malaria, hepatitis (and hopefully one day HIV) and secondly, by providing 
an industry capable of providing important industrial chemicals at low cost without 
depriving the communities of natural resources. Plant biotechnology could have a 
major impact on these aspects: both oral vaccines and industrially important 
chemicals could be manufactured in crop plants at low cost. The advantage of 
the production of these biomaterials is that they are renewable and their 
production would not stress the local environment (Somerville, 1993). It is in this 
vein that the project of investigating means of synthesising foreign proteins in 
plants was undertaken. 
TRANSGENIC PLANTS AS MANUFACTURERS 
INTRODUCTION. 
Recent developments ir:t molecular biology have made it possible to produce large 
amounts of useful chemicals in plants. In comparison to bacterial or yeast 
fermentations, crop plants are capable of producing these proteins at relatively 
high expression levels at low cost. Proteins are generally stable and fully 
functional (Herbers et al., 1995). 
Agracetus Inc., a biotechnology company based in Wisconsin, USA, was awarded 
the patent in 1992 for its particle-mediated gene delivery technology to create 
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plants that can produce high levels of biopharmaceuticals and other industrial 
enzymes in plant tissues. They maintain that their plant bioreactor production 
system (PBP) has several advantages over bacterial fermentation or cell culture 
systems. Microbial fermentations require corl'lplex machinery and input costs 
estimated to between $1 O 000 and $1 million per kilogram of crude extract. If the 
protein of interest is produced in seeds or tissue at 0, 1 % - 1 % of the total protein, 
the production costs are reduced to about $1 000 per kilogram of crude extract. 
PBP systems eliminate the potential of contamination of microbial or cell culture 
systems with harmful pathogens. Transgenic plants can produce biologically 
active proteins and be accumulated in food crops that already have a long history 
of safe use. Microbial and cell culture systems are difficult to scale up, the major 
problems being with aeration, cell density and product recovery. Proteins 
produced in plants either by gene insertion or utilising a viral vector can provide 
easy and consistent scale-up simply by increasing the acreage of the crop 
concerned (Donson et al., 1991) 
EXAMPLES OF PLANT-MADE PRODUCTS. 
It has been demonstrated that polyhydroxy butyrate (PHB}, a biodegradable 
plastic polymer, can be produced in transgenic Arabidopsis tha/iana. These 
plants produced approximately 100 µg PHB per gram of total fresh weight (Poirier 
et al., 1995). The same authors are now attempting to produce 
polyhydroxyalkanoates, naturally occurring po.lyesters that accumulate as 
inclusions in several bacteria, in plants. A.thaliana was chosen as a model 
system as it is closely related to the oil-producing crop oilseed rape, a target crop 
for the production of PHA on an agricultural scale. 
Transgenic plants can also be designed to synthesise enzymes for commercial 
and technical purposes. Plant cell-wall degrading enzymes are required by 
several industries to either purify plant derivatives or convert waste products of 
the food and paper-pulp industries to animal feed. To this end a thermostable 
xylanase from C/ostridium thermoceflum was expressed to high levels in 
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transgenic tobacco. The amount of protein obtained in plant extracts comprised 
approximately 4% of the total protein and it retained its enzymatic activity. 
Targeting the protein to the apoplastic space by the proteinase inhibitor II signal 
peptide made for easier purification of the enzyme from intercellular fluid extracts 
(Herbers et al., 1995). 
Biologically active peptides have also been produced successfully in Arabidopsis 
and oilseed rape. A portion of an Arabidopsis thaliana seed storage protein gene, 
the 2S albumin gene, is not highly conserved and was replaced with the sequence 
encoding the neuropeptide Leu-enkephalin. This pentapeptide, a protein which 
displays opiate activity, was chosen for its small size and availability of a 
commercially produced version for comparative studies. Tryptic cleavage sites 
were included at either side of the inserted leu-encepha!in protein, thereby 
allowing for the recovery of the peptide after digestion with trypsin from 2S 
albumin extracts (Vandekerckhove et al., 1989). Up to 200 nmol of peptide were 
recovered per gram of seed. 
Sijmons et al. (1990} set out to explore the potential of plants to produce 
commercially important proteins by expressing the human serum albumin protein 
(HSA) in potato plants. In man, HSA is produced as prepro-albumin by the liver 
and processed twice to yield the mature secretory polypeptide. These authors 
found that the prepro-signal sequence of HSA could target the protein across the 
membrane of potato cells, but that the recombinant protein was incompletely 
processed. They were able to construct a hybrid plant/human precursor which 
resulted in secretion of. correctly-processed HSA that was indistinguishable from 
the original human protein. The starch potato demonstrates the feasibility of 
harvesting a crop for two yields: the process of wet milling potatoes allows both 
starch from the tubers and a commercially viable protein from the liquid fraction to 
be harvested. The liquid fraction is usually a waste product (Sijmons et al., 1990). 
Gene transfer to plants also offers the opportunity for genetic modification of 
crops. The potential exists to improve the flavour of edible plant products by 
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genetic manipulation. The gene coding for monellin, a protein which elicits a 
sweet flavour, was placed under the control of fruit-ripening specific promoters 
and transferred to lettuce and tomato plants (Penarrubia et al., 1992 ). 
Expression of the gene in the transgenic plants resulted in the accumulation of 
monellin protein in tomatoes and lettuce leaves. This illustrates that gene transfer 
of foreign sequences offers an alternative means of enhancing the flavour and 
quality of fruits and vegetables. 
PLANT VIRUSES AS VECTORS 
The production of transgenic plants is a costly and lengthy process. An 
alternative to this approach is the engineering of simple plant viruses so that they 
will express foreign genes at high levels in infected plants. The major advantage 
of this technique is that it is far quicker to engineer a virus than it is to engineer a 
plant. A variety of foreign genes may be inserted into a viral vector with the 
distinct advantage that the virus product is expressed immediately, rather than 
after the weeks it takes to regenerate plants from transformed tissue (Boyer and 
Haenni, 1994 ). 
Nicotiana tabacum is a suitable crop for the production of viable proteins as it is 
fast-growing and can be infected with several types of plant viruses that are not 
too severe on the host plant. Tobacco crops provide a large yield per plant of leaf 
mass and the infrastructure is all ready in place for processing large amounts of 
leaf tissue. The concept of using plants as factories has captured the imagination 
of the popular press. Tom Turpen of Biosource Technologies is quoted in the 
New Scientist as saying that their system of using tobacco mosaic virus (TMV) to 
produce an experimental vaccine against malaria, could produce as much as 250 
kilograms of vaccine per month from a hectare of tobacco plants infected with the 
modified TMV (Coghlan 1995). 
DNA VIRAL VECTORS. 
Since the characterisation of plant DNA viruses there has been a growing 
interest in their potential as vectors for delivering genes into plants. Cauliflower 
mosaic virus (CaMV), a double stranded DNA virus which replicates by means of 
reverse transcription of its genomic RNA template, was the first virus to be used 
as a plant virus vector (Brisson et al., 1984; Mason et al. 1 SJ?). 
The non-essential CaMV ORF n was replaced with the dihydrofolate reductase 
(dhfr) gene, a gene which confers resistance to methotrexate in Escherichia coli 
(Brisson, et al., 1984). Turnip plants inoculated with the modified virus were 
found to develop symptoms in the same period as the control plants, suggesting 
that the inclusion of the dhfr gene was not detrimental to virus repHcation. Viral 
DNA carrying the dhfr gene was isolated from virus particles obtained from 
systemically infected leaves, proving that the insert had been retained in the viral 
genome. Methotrexate studies were done to indicate the functionality of the 
DHFR enzyme and found it to be fully active. However expression of DHFR was 
significantly reduced after two or three cycles of infection. This phenomenon of 
insert instability was later found to be independent of the insert size ( De Zoeten, 
1989 ). 
De Zoeten et al. (1989) were able to produce human interferon aD (IFN aD) in 
turnip plants using a CaMV ORF II vector. Greater insert stability was achieved 
by linking the IFN aD gene to the absolute beginning and end of the ORF II gene, 
thereby preserving the original ORF arrangement. Vectors carrying short 
untranslated regions flanking the inserted gene were found to be unstable. This 
confirms that CaMV could be used to successfully deliver and express foreign 
genes in plants provided that the original ORF organisation is maintained. The 
addition of any extraneous nucleotides before the inserted ORF resulted in the 
insert being lost after 2 - 3 cycles of inoculation (Brisson et al, 1984; De Zoeten et 
al., 1989). 
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Gerniniviruses are apparently suitable candidates for plant vectors as collectively 
they infect a wide range of monocotyledonous (monocot) and dicotyledonous 
(dicot) plants (Stanley, 1993). They replicate via a double stranded (ds) DNA 
intermediate in the plant cell nucl~us. The potential of maize streak virus (MSV) a 
geminivirus infecting monocots, as a gene vector, was investigated by Shen and 
Hohn (1994). A reporter gene coding for ~-glucuronidase (GUS) was inserted into 
the non-coding region of the genome of MSV and used to infect maize seedlings 
by using Agrobacterium-mediated inoculations. This MSV-GUS construct was 
found to induce more blue spots in maize seedlings than in control seedlings 
inoculated with only a GUS construct. The increase in GUS expression was even 
more pronounced 1 week after inoculation (Shen & Hohn, 1994). The MSV-GUS 
construct was however unable to move to adjacent tissues or induce symptoms in 
seedlings. A possible reason for the lack of movement of the 5.9 kb MSV-GUS 
construct could have been that it was too large to be packaged when compared to 
the 2. 7 bp naturally occurring MSV genome. 
Another problem en route to developing a geminivirus vector is the means of 
delivery of the vector. Few geminiviruses can be mechanically inoculated onto 
plants. Viral sequences can however, be introduced to the plant by using 
Agrobacterium containing the viral vector sequences (Stanley 1993), but this 
method of introducing the foreign sequence to the host plant would not be feasible 
for large scale inoculations. 
African cassava mosaic virus (ACMV), another member of the Geminiviridae, has 
also been investigated for its potential as a plant expression vector. The 
chloramphenicol acetyl transferase (cat) gene was inserted in place of the ACMV 
coat protein gene and successfully expressed in tobacco plants. However, vector 
instability during plant infection poses a major problem to the development of a 
geminiviral vector. Vectors appear only to remain stable during systemic infection 
when they are comparable in size to the wild type component. This problem of 
instability due to size constraint could be overcome by making use of a binary 
vector system whereby the viral replication associated genes are supplied in trans 
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from integrated copies in the plant genome. These constitutively produced 
proteins could support the efficient replication of replication protein deficient 
ACMV replacement vectors, thereby supporting the expression of ttie protein of 
interest (Stanley, 1993). 
RNA VIRAL VECTORS. 
Viral expression vectors based on RNA viruses have several distinct advantages 
over integration of foreign proteins into plant genomes: RNA viruses have wide 
host ranges; they are able to move from cell to cell mediated by virally encoded 
movement proteins; they exhibit rapid systemic spread in plants; their infections 
are maintained for the lifetime of the plant; their RNA is replicated to high levels 
as autonomous sequences in the host which results in rapid and productive 
cytoplasmic gene expression (Ahlquist et al., 1987; Donson et al., 1991 ). · 
Tobacco mosaic virus (TMV) and brome mosaic virus (BMV) are two examples of 
RNA viruses that have been used successfully as plant expression vectors. The 
ability to effectively manipulate RNA viruses through a cDNA copy allows for 
simpler cloning strategies and increases their appeal as viral vectors. The cDNA 
copy can then be transcribed in vitro to produce infectious RNA molecules 
(Donson et al., 1991; Hamamato et al., 1993; Kumagai et al., 1993). 
Although perhaps the most successful RNA virus engineering recently has been 
that of cowpea mosaic virus, this vector system relies on the expression of 
peptide sequences inserted into the capsid and is not capable of expressing full-
length foreign polypeptides. It will therefore not be discussed in .this review, but 
will be dealt with below in the section on vaccines (Usha et al., 1993). 
The TMV genome consists of a single 6395 nucleotide molecule of messenger 
sense, single stranded RNA encoding four proteins. The two replicase proteins 
are translated directly from the genomic RNA, while the movement protein and the 
coat protein are translated from two 3'-coterminal subgenomic RNA's produced 
during replication. Its helical structure means that there are no packaging 
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constraints that are found in nonhelical viruses (Donson et al., 1991). TMV easily 
infects plants and a large amount of virus is produced after infection with the virus 
(Hamamoto et al., 1993). Early attempts to express foreign proteins in TMV by 
gene replacement resulted in either failure of the modified virus to infect plants 
(Joshi et al. 1990) or loss of long distance movement (French et al. 1986). 
Addition of an extra viral subgenomic promoter to drive expression of the foreign 
gene resulted in the gene sequence being deleted. This was thought to be due to 
recombination between the two repeated subgenomic promoter sequences within 
the viral construct (Dawson et al. 1989). Donson et al. (1991) avoided the 
problem of deletion of foreign inserts due to homologous flanking sequences by 
using two heterologous promoters in their vector. They used the TMV-U1 
promoter to drive expression of the subgenomic RNAs for the foreign gene and 
the functionally similar odontoglossum ringspot virus (ORSV) promoter to 
synthesis ORSV coat protein. ORSV showed very low sequence similarity (45%) 
to TMV-U1 in that region. Two reporter genes were inserted independently into 
the vector, TB2; namely DHFR and the neomycin phosphotransferase (NPTll) 
genes. The constructs both moved systemically in Nicotiana benthamiama 
although the symptoms were milder than for wild type TMV U-1. Hybrid RNAs 
containing both the TMV U-1 and the inserted sequences were encapsidated by 
the ORSV coat protein, thereby facilitating their transmission on passage to 
subsequent plants. DHFR was retained without any deletions in plants after 10 
passages. The NPTll gene showed sequence deletions of different portions in 
each independent passage series of the vector. Such deletions would not 
appear to be a defect of the TB2 vector, based on the stability of the DHFR 
sequence, but rather an inherent feature of the inserted sequence itself (Donson 
eta/., 1991). 
Vector TB2 was subsequently used to express biologically active a.-trichosanthin 
to high levels in tobacco plants (Kumagai et al., 1993). The a.-trichosanthin gene 
was placed under the control of the TMV U-1 subgenomic promoter in the TB2 
vector and inoculated onto tobacco plants. Two weeks after infection, a.-
trichosanthin had accumulated to levels of at least 2% of the total soluble protein. 
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This demonstrated that vector TB2 provides an effective tool for expression of 
foreign sequences in plants. 
Hamamoto et al. (1993) made use of a six base sequence that follows the stop 
codon for the TMV 130K protein gene and which allows readthrough of the stop 
codon to create a novel vector. They designed an expression vector in which the 
six base sequence is inserted immediately after the stop codon for the coat 
protein (CP) gene and immediately upstream of the inserted foreign gene 
sequence; in this case the angiotensin-1-converting enzyme inhibitor peptide 
(ACEI). The vector produced both intact CP as well as a fused protein consisting 
of CP and ACEI (CP-ACEI). The amount of CP-ACEI produced was 100µg/g of 
fresh tissue in both the tobacco and tomato leaves and 1 O~tg/g of fresh tissue in 
tomato fruit. Both CP and CP-ACEI were found to successfully encapsidate the 
TMV vector RNA. This unexpected result may be due to the fact that the C-
terminal portion of the coat protein projects out from the TMV particle. They are in 
the process of determining whether the vector can be used for the production of 
longer peptides or proteins. 
Brome mosaic virus (BMV) is a small isometric virus of grasses. Its genome is 
divided into three separate RNA components which are packaged in separate 
virions as capped, messenger sense, single stranded RNAs. RNA's 1 & 2 
encode the replicase proteins. RNA 3 encodes both the movement protein as well 
as the highly expressed coat protein from the subgenomic RNA 4, produced from 
the 3' portion of RNA 3 (Ahlquist et al., 1987). The ability of this subgenomic 
RNA to direct high-level protein synthesis makes it an ideal candidate for an 
expression vector. French et al. (1986) developed an in vitro transcription system 
to express infectious BMV RNAs from cloned complementary DNA (cDNA) copies 
of the genomic components. The cloned cDNA copies allowed for recombinant 
DNA techniques to be used to create hybrid viral RNAs. Initial vector studies 
were done using variants of RNA 3 where the CP gene was replaced by the 
chloramphenicol acetyltransferase (cat) gene. Infectious transcripts of RNAs 1 & 
2 and the hybrid RNA 3 were used to infect barley· protoplasts and monitored for 
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CAT activity. CAT was expressed from those RNA 3 constructs carrying the CAT 
insert in the same orientation as the original viral genes. Its expression was 
improved when the inserted gene was placed· in frame with the upstream CP 
initiation codon (French et al., 1986). It was also shown that the RNA3/CAT 
hybrids accumulated to a lesser degree than wild type RNA3 in infected 
protoplasts. Ahlquist et al. (1987) demonstrated that capped BMV transcripts 
were infectious to whole plants whereas noncapped transcripts were not. 
Mori et al. (1993) were able to successfully produce human gamma interferon 
(IFN-y) in tobacco protoplasts using a BMV-derived vector system. The BMV 
strain ATCC66 used in their study encodes two types of coat protein: full length 
CP1 and· a truncated version, CP2 which is translated from a second initiation 
codon downstream of CP1 (Mise et al., 1992). Chimeric RNA clones were 
constructed by replacing each of the viral genes with IFN-y using biologically 
active cDNA clones of BMV. They found that the hybrid RNA transcripts bearing 
IFN-y in place of the CP2 were replicated most efficiently and produced the most 
foreign protein (approximately 10% of total extractable protein). IFN-y produced 
in tobacco protoplasts retained its biological activity but at a reduced level when 
compared to that of IFN-y produced in animal cells. 
VACCINE PRODUCTION IN PLANTS 
Plants hold great promise as low-cost vaccine production systems. Vaccines 
derived from plants should be simpler to harvest than vaccines made in the 
conventional ways of fermentation and cell culture, and could potentially be stored 
at room temperature, thereby eliminating the nee.d for the cold chain (Coghlan, 
1995). Plant vaccines also eliminate the fear of contamination with potentially 
infective animal viruses which always is a problem with vaccines manufactured in 
animal tissue culture (Thanavala et al., 1995). 
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Mason et al. (1992) and Thanavala et al. (1995) were able to express the hepatitis 
B surface antigen (HBsAg) in transgenic tobacco plants. Using an enhanced 
CaMV promoter linked to the tobacco etch virus (TEV) 5' nontranslated leader 
sequence they were able obtain HBsAg yields of up to 66 ng/mg of soluble 
protein. The plant produced antigen was quantified in an immunoassay system 
using monoclonal antibodies directed against serum HBsAg. The HBsAg 
produced in tobacco aggregated to form pseudocapsid particles virtually 
indistinguishable fron serum derived HBsAg with respect to size, density 
sedimentation and antibody binding. 
The authors went further to study the immunogenicity of the plant-derived HBsAg. 
Both tobacco-derived HBsAg and yeast-derived HBsAg were used to immunise 
BALB/c mice, and the immune responses to both antigens were compared. They 
found that the tobacco-derived HBsAg could elicit HBsAg-specific antibodies and 
prime T-cells in vivo that could be stimulated in vitro by the yeast-derived HBsAg, 
currently used in vaccines (Thanavala et al., 1995). 
An intriguing prospect is finding a way of using edible plants to deliver vaccines 
orally. This concept has generated a lot more interest since the discovery of a 
common mucosa! immune system where specific antigen-activated lymphocytes 
from the gut can disseminate immunity in the intestinal, genital and respiratory 
tracts (Holmgren et al., 1994). The binding subunit of Escherichia coli heat-labile 
enterotoxin (L T-8) is a highly active oral immunogen. Haq et al. (1995) made both 
transgenic tobacco and potato plants expressing L T-8. The peptide was 
produced in the correct conformation and reached levels of 5µg/g of total soluble 
leaf protein and 30 µg/g of soluble protein in potato microtubers. Protein levels 
were higher in constructs bearing the microsomal retention signal that retains the 
peptide in the endoplasmic reticulum with L T-B reaching !eves of 14 µg/g of totoal 
soluble leaf protein and 110 ~Lg/g of soluble potato microtuber protein. To study 
the oral immunogenicity of the plant derived L T-8, Balb/c mice were given crude 
soluble extract from transgenic tobacco leaves while control mice were dosed with 
an eqivalent amount of L T-8 derived from E.coli. Amounts of serum and mucosa! 
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antibodies were similar in both groups indicating that the plant-derived antigen 
retained the immunogenic qualities of the bacterial toxin. Neutralisation studies 
demonstrated that both groups of mice were protected to the same extent (Haq et 
al., 1995). The most encouraging result in this study was that feeding mice 
potatoes expressing LT-8 generated a sound oral immune response to the toxin. 
This clearly demonstrates the feasibility of using transgenic plants in the 
production and delivery of subunit vaccines. 
Chemically synthesised peptides are often only immunogenic when linked to a 
larger carrier molecule. Plant viruses could possibly serve as cheap, effective 
antigen presentation systems. Usha et al. (1993) cloned an oligonucleotide 
encoding an epitope derived from VP1 of foot-and-mouth disease virus (FMOV) 
into the region of the cowpea mosaic virus (CPMV) encoding the small coat 
protein. The chimaeric construct bearing the epitope as an insert was able to 
direct capsid formation and infect whole cowpea plants. The modified virus was 
however unable to infect cowpeas systemically. FMDV-specific serum reacted 
with peptide extracted from infected leaves, demonstrating that it was correctly 
synthesised and folded. Subsequent analysis of progeny RNA produced in these 
plants revealed that the inserted sequence was rapidly lost during serial 
passaging, presumably due to homologous recombination between two direct 
repeats, created during the cloning process, on either side of the inserted 
sequence (Porta et al., 1994). 
The vector was redesigned to carry the insert in the centre of the f38-f3C loop of 
the coat protein (Porta et al., 1994). This site is exposed on the surface of the 
virus and is potentially the optimum site for any insertion. Two epitopes; one 
derived fron human rhinovirus 14 (HRV-14) and another from human 
immunodefieciency virus type 1 (HIV 1) were cloned into this site in such a way so 
as not to generate repeated sequences. Both chimaeric viruses induced normal 
CPMV symptoms on tobacco. Western blot analysis on virions purified from 
infected leaf tissue showed that both the HRV 14 and HIV 1 epitope possessed 
their correct antigenic properties. Virus specific antibodies to each of the 
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chimaeric viruses were induced in the sera of rabbits injected with purified 
chimaeric virions (Porta et al., 1994). 
TMV has been engineered to carry and display an immunogenic malarial epitope 
on its surface. The 8-cell epitope was inserted into the surface loop of the coat 
protein or fused to the C terminus using a leaky stop codon. Tobacco plants 
systemically infected with either construct gave high titres of genetically stable 
recombinant virus which bound very strongly to monoclonal antibodies specific for 
malaria (Turpen et al., 1995 ). 
CUCUMBER MOSAIC VIRUS 
INTRODUCTION. 
Brome mosaic virus (BMV), a tripartite virus belonging to the family Bromoviridae 
(Ahlquist et al., 1987), was used to produce large quantities of human gamma 
interferon in tobacco protoplasts. This was the first example of a foreign protein 
being produced by an icosahedral RNA virus in plant cells (Mori et al. , 1993). 
We have chosen to investigate the potential of another member of the 
Bromoviridae, cucumber mosaic virus (CMV), as a plant expression vector. CMV 
has a much broader host range than BMV, infecting both monocotyledonous 
(monocot) and dicotyledonous (dicots) plants. It has the largest known host range 
of any virus, infecting crops as diverse as bananas in Morocco, melons in Spain 
and sweet potato in Israel (Palukaitis et al., 1992). It is precisely for its 
detrimental impact on agriculture that CMV has been so extensively studied. 
Several strains of this tripartite RNA virus have been fully sequenced (Davies and 
Symons, 1988; Rizzo and Palukaitis, 1988, 1989; Owen et al., 1990; Ding et al., 
1994) and infectious cDNA copies of the viral components (Ahlquist et al., 1987; 
Palukaitis et al., 1992; Boyer and Haenni, 1994; Pogany et al., 1994; Ding et al., 
1995) have greatly· aided studies on the replication and life cycle of this 
pathogen. Mild strains of CMV exist that are efficient at systemically infecting the 
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host plant while not reducing the yield of plant material to a great extent 
(Palukaitis et al., 1992). The CMV genome consists of 3 segments of single 
stranded (ss) RNA, each of which possesses the necessary signals for replication 
by the virus replication machinery. It is an ideal virus to use in constructing a 
viral vector as one need engineer only one segment of the viral genome as 
opposed to the entire genome of, for example; TMV. We envisaged the use of an 
artificial satellite RNA-like construct derived from CMV RNA 3 for the infective 
expression of foreign genes in a wide. variety of host plants susceptible to this 
virus. Herewith follows a brief review of CMV and its potential as a plant 
expression vector. 
TAXONOMY OF CMV. 
Cucumber mosaic virus (CMV) belongs to the taxonomic family Bromoviridae 
(Fig. 1.1) and genus Cucumovirus. CMV is the type member of the genus. Strains 
of CMV can be divided into two subgroups based on their antigenicity and severity 
of the symptoms. Subgroup I CMVs produce severe symptoms on their hosts, the 
type member being CMV Y which induces severe yellowing and mosaic symptoms 
on Nicotiana g/utinosa. Subgroup II includes the milder strains of CMV, the type 
member being CMV M (Owen & Palukaitis, 1988; Rybicki, 1995). All viruses show 
strong similarities in particle morphology .and genome organisation. 
PARTICLE STRUCTURE. 
Three native viral particles are required for infection by CMV, each particle 
consisting of the same protein shell, yet containing different RNA species 
(Palukaitis et al., 1992). RNAs 1 & 2 are found in their own protein shells, but 
both RNA 3 & 4 are encapsidated together in a single particle. The separate 
CMV particles are not readily discernible from one other, each having the same 
diameter of about 28 nm and a sedimentation coefficient of approximately 98.6 
Svedbergs (Rybicki, 1995). 
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CAPSIO MORPHOLOGY 
The capsid consists of 180 identical protein subunits arranged in pentamer and 
hexamer clusters with T = 3 symmetry. The coat protein gene of CMV is encoded 
on RNA 3, but expressed only from the subgenomic RNA 4. RNA 4 produces a 
single protein product of Mr 24,500. 
CMV particles are icosahedral with a diameter of about 28 nm. The genomic RNA 
lines the protein shell on the inside, penetrating the protein layer to a depth of 
2nm, thereby adding to the stability of the virion. Lysine residues on the coat 
protein appear to be critical in the stabilization of the capsid as they are thought to 
interact with the negatively charged phosphate groups of the viral RNA These 
· electrostatic interactions are easily disrupted in high salt concentrations or in the 
presence of the detergent SOS, allowing the particles to dissociate into their 
protein and RNA components (Palukaitis et al., 1992). Fully functional CMV 
particles can be reassembled by lowering the salt concentration or removing the 
SOS. Heterologous reassembly has been demonstrated in vitro between the 
proteins and RNA of CMV and TAV (Chen and Francki, 1990) indicating that this 
association is non-specific .. 
-------------
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BROMOVIRIDAE 
I 
llarviruses Alfamoviruses Cucumoviruses Bromoviruses 
TSV AIMV CMVI BMV 
POV CMVll CCM\i 
ApMV TAV BBMV 
PSV 
Figure 1.1. Flow chart showing the composition of the family Bromoviridae. 
_Abbreviations are as follows: TSV, tobacco streak virus; POV, prune dwarf virus; ApMV, apple 
mosaic virus; AIMV, alfalfa mosaic virus; CMV, cucumber mosaic virus subgroup I or II; TAV, 
tomato aspermy virus; PSV, peanut stunt virus; BMV, brome mosaic virus; BBMV, broad bean 
mottle virus and CCMV, cowpea chlorotic mottle virus. 
GENOME STRUCTURE. 
Single stranded (ss) RNA makes up about 18% of each particle's weight. CMV 
has three species of messenger sense RNA; RNAs I, 2 & 3 (Table 1.1 ). RNA 4 is 
a subgenomic RNA co-terminal with the 3' end of RNA 3 and is encapsidated with 
RNA 3 in a single particle. All four RNAs contain a conserved untranslated 3'-
terminal region and their 5' termini have 7-methylguanosine caps (Rybicki, 1995). 
RNA 4A has recently been described by Ding et al. (1994) and is derived from 
RNA 2 (Fig 1.2). 
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RNA species Nucleotides ORF Mr of protein (kDa) 
RNA 1 3357 1a 111 
RNA2 3050 2a 97 
RNA3 2216 3a 30 
RNA4 1031 CP 24 
RNA4A 682 2b 11.3. 
Table 1.1 
MOLECULAR CHARACTERISTICS OF Fny-CMV, A SUBGROUP I MEMBER. 
"Characterised for CMV Q, subgroup II. (Ding et al., 1994) 
RNA 1. 
RNA 1 encodes an 111 kDa polypeptide, 1 a from a single open reading frame 
(Fig.1.2). Protein 1 a, together with the 2a protein and a 54kDa host derived 
protein, has been demonstrated to form part of the active viral replicase complex 
(Hayes and Buck, 1990 a&b). The carboxy terminal 141 amino acids of the 1a 
protein are predominantly basic, a common feature among nucleic acid binding 
proteins (Palukaitis et al., 1992). This region also contains the six conserved 
motifs found in both DNA and RNA helicases, suggesting a functional role for this 
protein in the replicase complex, either for unwinding a double stranded 
replicative intermediate or unwinding of extensive secondary structure in the ss 
genomic RNA molecule (Kamer and Argos, 1984; Habili and Symons, 1989; 
Palukaitis et al. 1992). 
RNA2. 
RNA 2 encodes a single polypeptide of Mr 94kDa (Table 1.1 ), which has also 
been implicated in viral replication (Hayes and Buck, 1990 a&b). The sequence 
contains several motifs common amongst other Bromoviruses as well as in the 
183K protein of TMV, including the highly conserved amino acid motif glycine-
aspartic acid-aspartic acid (GOD), associated with viral replicase proteins (Kamer 
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and Argos, 1984; Habili and Symons, 1989; Palukaitis et al., 1992). The viral 
replicase is able to accept messenger sense RNA and synthesise double-
stranded replicative intermediary RNA and genomic RNA for encapsidation. 
Despite the homology with other replicase associated proteins at the amino acid 
level, the replicase is highly template specific, accepting only CMV as a template 
( Palukaitis et al., 1992). 
The production of a new CMV protein (2b) has recently been described by Ding et 
al. (1994). They determined the complete nucleotide sequence of CMV-Q RNA 
4A and found it to be a novel subgenomic RNA derived from RNA 2. The 2b open 
reading frame of 100 codons overlaps the C-terminal portion of the 2a gene. RNA 
4A is 682 nucleotides long and is 99.3% homologous to the terminal 682 bases of 
RNA 2 of CMV Q, a subgroup II strain. Sequence comparison to other published 
sequences revealed the presence of this extra ORF in CMV strains Y and Fny, 
both subgroup I strains, as well as in the cucumoviruses TAV and PSV J. The 
sequence was however found to be absent in bromoviruses and alfalfa mosaic 
virus, indicating that this is a unique feature of cucumoviruses (Ding et al., 1994). 
1 a+2a+54k= REPLICASE 
CP =COAT PROTEIN 
3A = MOVEMENT PROTEIN 
2b =? 
Figure 1.2. DIAGRAM O,F THE GENOME STRUCTURE OF CMV. 
RNA1 
RNA2 
RNA3 
RNA4 
RNA4A 
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RNA 3 AND 4. 
RNA 3 of CMV contains two open reading frames (Fig 1.2). The 5' -proximal ORF 
encodes a protein that has been shown to be involved in movement of the virus in 
the plant host, the 3a protein (Davies and Symons, 1988; Palukaitis et al., 1992). 
The second ORF encodes the 24kDa coat protein. It is translated from the 
subgenomic RNA 4 which .is colinear with the 3' terminal end of RNA 3 (Fig 1.2). 
The nucleotide sequence between CMV subgroup I RNA 3s is very highly 
conserved in isolates from different countries and passage histories, indicating a 
possible common viral function for RNA 3 amongst these viruses. This 
conservation of sequence is not extended to subgroup II CMV strains which 
display considerable divergence to CMV subgroup I types (Owen et al., 1990). 
The divergence of nucleotide sequence among other members of the 
Bromoviridae is not reflected at the level of secondary structures where the 
conservation suggests a functional role for the 5' and 3' UTRs as well as the 3a 
protein (O'Reilly et al., 1991 ). 
Suzuki et al. (1991) constructed cDNA mutants from full-length CMV Y RNA 3 to 
have deletions in either the 3a or coat protein sequences. These mutants were 
able to replicate in tobacco protoplasts but were unable to induce wild type 
systemic symptoms on tobacco when inoculated together with infectious 
transcripts of RNA 1 & 2. Their results suggested that both the 3a protein and the 
coat protein are involved in virus transport in the host plant tissues. Subsequent 
studies on CMV Kin strain have proved that the CMV 3a protein is involved in cell-
to-cell trafficking by increasing the size of the plasmodesmata (Vacquero et al., 
1994; Ding et at, 1995). 
RNA 3 has recently been implicated in inducing a hypersensitive response in 
Arabidopsis thaliana. CMV Y causes necrotic lesions on A. thaliana ecotype C24 
-.. 
whereas CMV 0 spreads systemically in this host. In plants infected with CMV Y, 
the virus was confined to the inoculated leaves and levels of pathogenesis-
related-1 protein (prp-1) were found to be raised in the regions surrounding CMV 
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induced necrotic lesions. CMV 0 spread systemically in A. thaliana plants, but did 
not show raised levels of prp-1. Comparison of the host responses to 
pseudorecombinants between CMV Y and CMV 0 showed that the prp-1 inducing 
element was confined to RNA 3 (Takahishi et al., 1994). 
The coat protein has been identified as the chlorosis-inducing domain of CMV. 
CMV Fny causes a green mosaic pattern on tobacco while CMV M induces a 
bright yellow/white chlorosis. Recombination between cDNA clones of the RNA 3 
from these two strains localised the chlorosis-inducing region to a section of the 
coat protein gene containing two nucleotide differences(Shintaku et al., 1992). 
These authors went on to use site directed mutagenesis to demonstrate that the 
secondary structure at these amino acids was the determining factor in chlorosis 
induction and not the nucleotide sequence as such. 
5' TERMINAL STRUCTURE. 
Structural features at, or near, the 5' ends of many viral RNAs are thought to play 
an important role in viral replication. The first 150 base pairs of each CMV RNA 
could form a strong stem loop structure, similar to that found in BBMV (Pogany et 
al., 1994) and which appears to play an important role in the replication of beet 
necrotic yellow vein virus, another ssRNA virus (Gilmer et al., 1993). 
The presence of a 5' 7-methyl guanosine cap structure enhances the stability and 
infectivity of BMV transcripts (Ahlquist et al., 1987; Hayes & Buck, 1990b). The 
yield of progeny viral RNA from inoculated cDNA decreases seriously with the 
addition of extra, non-viral bases at the 5' end (Janda et al., 1987; Hayes and 
Buck, 1990b). The mechanism of this decrease in infectivity is not known. It is 
suspected that additional 5' nucleotides result in extra bases at the 3' terminus of 
the (-) strand and that this interferes with the initiation of(+) strand synthesis by 
the viral replicase (Ahlquist et al., 1992). 
21 
THE INTERGENIC REGION. 
CMV carries a third untranslated region on its RNA3, the intergenic region (IGR) 
as illustrated in figure. 3.4. This region has been found to play an important role in 
the replication of BMV RNA 3. (Marsh et al., 1991 ). Deletion of sections of the 
internal control region of BMV decreased RNA 3 replication in protoplasts to less 
than 15% of the wild type levels (Pogue et al., 1992). 
Boccard and Baulcombe (1993) were able to demonstrate that mutants in the 
CMV RNA 3 of the Kin strain that resulted in truncated coat protein being 
produced, were still able to replicate to levels of 20% of the wild type virus. 
Mutants containing similar deletions in the coat protein and in the intergenic 
region were however unable to replicate at all. The orientation of the inserted 
intergenic region was also important as insertion of the IGR in the incorrect 
orientation did not restore the replication ablilty to the CP-IGR deleted RNA 3. By 
constructing various deletion mutants of the IGR, they were able to show that a 
250-nucleotide region in the intergenic region was required for CMV RNA 3 
accumulation. This region contains a conserved UA tract also found in other 
subgroup II CMVs (Boccard and Baulcombe, 1993). A second conserved motif in 
the IGR has a similarity to the ICR2 motif found in the RNA polymerase Ill 
promoter of eukaryotes. This motif is also found in the 5'-end of BMV RNAs 1 & 2 
(Marsh and Hall, 1989). The IGR appears to affect (+)-strand accumulation in 
both CMV and BMV (Pogue et al., 1992; Boccard and Baulcombe, 1993) and that 
the ICR2-like motif is necessary for efficient synthesis of RNA 3. The presence of 
these ICR2-like regions suggests that a host RNA polymerase Ill subunit and/or 
one of its cofactors could participate in viral RNA replication. However, none of 
these components has a molecular mass close to that of one of the host factors 
associated with the polymerase of CMV or BMV (Zaccomer et al., 1995). 
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3' -TERMINAL STRUCTURE. 
All three CMV RNAs have a conserved, untranslated 3' terminal region of about 
200 nucleotides. This common sequence takes on one of two structures 
depending on the presence or absence of Mg2+. If Mg2+ is absent, the 3' terminus 
. 
takes on a tRNA-like structure which in turn can be charged with tyrosine by plant 
derived amino acyl tRNA synthetases (Palukaitis et al., 1992; Rybicki, 1995). The 
presence of Mg2+ destabilises the hairpins to form a pseudoknot (Palukaitis et al., 
1992). 
The addition of 6 to 33 extra non-viral nucleotides at the end of the 3' terminus of 
BMV does not appear to affect infectivity of transcripts (Ahlquist et al., 1987; 
Suzuki et al., 1991 ). These transcripts would not have been able to be 
aminoacylated and yet were equally infectious in protoplasts as transcripts lacking 
the 3' extensions. This would suggest that aminoacylation is not required in the 
initial stages of infection (Ahlquist et al., 1987). 
VIRUS REPLICATION. 
CMV replication appears to be very similar to other RNA viruses. A general life 
cycle of the virus can be drawn up by relying on data common to several plant 
and animal RNA viruses. 
Entry. 
CMV is transmitted by more that 60 species of aphids in a non-persistent manner 
(Rybicki, 1995). Recent studies on both potyviruses and cucumoviruses have 
shown that the efficiency of transmission is primarily a function of the coat protein 
of the virus (Perry et al., 1994). Chen and Francki (1990) have demonstrated by 
means of in vitro encapsidation studies that the transmissibility phenotype of 
these viruses is _conferred by the coat protein. Once inside the host cell the CMV 
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must disassemble to release the viral RNA The exact mechanism of uncoating 
remains unclear. 
Replication. 
RNAs 1 & 2 are immediately translated by the host cytoplasmic ribosomes to 
make proteins 1 a and 2a (Palukaitis et al., 1992). These two proteins, together 
with the 54kDa host protein, form the viral replicase (Hayes and Buck, 1990 a&b), 
which becomes associated with the genomic viral RNA It is thought that the 
replicase recognises the secondary structure at the 3' end of the RNA as this 
feature is so highly conserved amongst the RNA viruses. This has been 
demonstrated for BMV where it was found that the 3' terminal structure, common 
to all the Bromoviridae, contains all the signals required for the initiation of 
replication (Miller et al., 1986). A complementary RNA of negative sense is 
+ve ssRNA Replicase 
5' UTR 3' UTR 
-ve ssRNA 
~ dsRNARI 
5' UTR 3' UTR 
Figure 1.3. Proposed replication strategy of CMV. 
The replicase complex recognises the 3' terminus of the (+) genomic RNA. It synthesises (-) sense 
RNA from the (+) template to make a double stranded (ds) replicative intermediate (RI) RNA. 
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synthesised off the messenger sense genomic template RNA to form a double 
·stranded (ds) replicative intermediate (RI) (Fig. 1.3). 
At some point the a switch occurs and the replicase commences synthesising 
messenger sense RNA from the negative sense templates. It is thought that the 
5' end "breathes" by forming a stem-loop structure in the ds RNA RI complex. The 
replicase would appear to recognise this loop on the negative strand and 
synthesise messenger sense genomic RNA from either the ds RI or ss negative 
sense RNA This recognition appears to occur more efficiently than at the 3' end 
structure of the genomic RNA, as the amount of positive sense RNA is usually two 
orders of magnitude higher than negative sense RNA The intergenic region of 
RNA 3 is also capable of forming a stemloop structure (Fig. 1.4). This feature 
may be even more efficient at capturing the replicase complex as more of the 
subgenomic RNA 4 is made than any other RNA in the infection process. 
Mutations of the 2a protein of BMV have altered the ratio of ( +) to (-) strand RNA 
synthesis (Kroner et al., 1989). However studies on BMV replication in 
protoplasts suggest that the coat protein may be the regulator of ( +) strand 
synthesis as the levels of (+) and (-) RNAs 1 & 2 are nearly identical in the 
absence of RNA 3. Virus formation could remove ( +) RNA from the replicating 
pool thereby favouring its formation to maintain an equilibrium. Marsh et al. 
(1991) implicated sections of the intergenic region as determinants of asymmetric 
replication in BMV. 
More research is needed before a clear picture of the replication of CMV can be 
described. What is clear from the present literature is that there is no single 
mechanism of regulation of synthesis of the various(+) and(-) viral RNAs. 
Replicase 
3A 
Protein 
5'UTR IGR 
Coat 
Protein 
Subgenomic 
RNA4 
+ve sense 
·3'UTR 
Figure 1.4. Proposed replication strategy of CMV (cntd.) 
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The 5' end and the intergenic region of the RI is proposed to form a stem-loop which is recognised 
by the replicase complex. (+) sense RNA is synthesised from the (-) strand of the RI. 
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DISCUSSION 
The production of foreign proteins in plants is fast becoming routine for a number 
of crop species. The process of generating transgenic plants expressing the gene 
of interest typically depends on the transformation of plant leaf discs, protoplasts 
or callus tissue with cloned DNA, selection for transformation by expression of a 
marker gene and regeneration of the material into whole plants. Transformed 
regenerants must be allowed to set seed before enough plants can be obtained to 
allow any reliable estimates of the yield of foreign protein. The levels of 
expression of the transgene are generally unpredictable, depending on transgene 
copy number and site of integration into the plant genome (Finnegan & McElroy, 
1994 ). This can largely be compensated for by regenerating many independent 
transformants and screening for the desired trait. These procedures typically take 
weeks and even months in some crop species. Although there are several cases 
. of stable expression, it would appear that a large number of transgenes are 
inactivated by the host; a phenomenon known as gene silencing (Finnegan & 
McElroy, 1994). The integration of foreign DNA into the plant genome is often 
unstable following propagation, leading to the loss of the newly aquired gene 
(Finnegan & McElroy, 1994). 
An alternative approach to the expression of foreign genes in plants has been 
developed over the last couple of years which has none of the drawbacks 
associated with the plant transformation system. It is now possible to engineer 
simple plant viruses so that they will express foreign genes at high levels in 
infected plants (Kumagai et al., 1993; Hamamoto et al., 1993; Thanavala et al., 
1995), at a time and plant developmental stage of the experimenter's choosing in 
as wide a range of crops as are infected by the virus. The major advantage of this 
system is that it is far easier to manipulate a small viral genome than it is to 
manipulate a plant genome. A segmented RNA virus such as CMV offers a more 
simplified approach as its largest genome segment is 3.3kb compared to TMV, 
another RNA virus with a genome of 6.3kb. A distinct advantage of virus-
mediated gene expression is that the engineered product may be tested 
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immediately it is made by simply infecting the plant. This eliminates the weeks 
and months required to generate transgenic plants to express the same protein. 
The system is easily scaled up to increase the amount of protein produced by 
merely increasing the number of plants inoculated with the modified virus (Donson 
et al., 1991 ). This system also eliminates the use of sel'ectable markers such as 
antibiqtic resistance genes, as if the virus infects, the protein will be expressed as 
a matter of course. A further advantage is that it is of no consequence if the 
protein is lethal to the plant: as long as the plant tissue is harvested before it dies, 
the product is still extractable. 
Although transgenic plants per se are not as flexible a system, they could be used 
in conjunction with viral vectors to limit viral escape. The viral replication functions 
could be supplied in trans in the host plant genome (Stanley, 1993) and the gene 
to be expressed would be inserted in place of the excised gene. The deletion of 
such an essential gene from the viral genome would cripple the virus and 
hopefully prevent its escape into the environment . This process could also be 
applied to DNA viruses (caulimoviruses and geminiviruses) to overcome the size 
constraint on inserts found in these viruses (De Zoeten, 1989; Stanley, 1993). As 
mentioned previously, DNA vectors based on geminiviruses are difficult to 
introduce into their host plants (Stanley 1993; Shen and Hohn, 1994). DNA 
viruses would appear to be ideal for expressing foreign genes in plants as the 
viral genome could be directly manipulated without having to make a 
complementary DNA copy of the viral genome first, as is the case with RNA 
viruses. 
Viruses can also be used not only to synthesise foreign proteins, but as epitope 
presentation systems. CpMV, another segmented RNA virus, has been 
sucessfully used to express two epitopes; one from HRV-14 and another from 
HIV, on the surface of its capsid (Porta et al., 1994). This yet again demonstrates 
the flexibily of an RNA viral expression system as opposed to expressing the gene 
of .interest in a transgenic plant. 
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OBJECTIVES OF THE PROJECT 
As can be seen from the foregoing, there are numerous ways of expressing 
foreign proteins in plants; from creati.~g a transgenic plant to express the desired 
protein, to having a modified virus synthesise it. The objective of this project was 
to express a protein constitutively in a tobacco plant at a low level of expression 
and then show increased expression utilising a plant expression vector. The 
transgenic plant would act as a suitable positive control for subsequent analysis 
of the vector product at the protein and RNA levels. 
The L 1 capsid protein of HPV was chosen as it has not been previously 
expressed in a plant system and a DNA clone of it was readily available. The L 1 
capsid protein of HPV is notoriously difficult to express in E. coli, although it has 
been expressed in the correct conformation in human cos cells and also in insect 
cells (Hines et al., 1994). The potential also exists to use this protein as a human 
vaccine to HPV as animals vaccinated with L 1 of related papillomaviruses have 
been protected against subsequent challenge by the wild type virus (Jarret et al., 
1991; Campo et al., 1993). The success of the tobacco expressed L T-8 in 
generating a suitable antibody response in mice after oral vaccination (Haq et al., 
1995), bodes well for oral immunisation of individuals utilising the L 1 of HPV-16. 
CMV was chosen for modification into a viral vector as a near relative, BMV has 
been shown to be effective in expressing a foreign protein in tobacco protoplasts 
(Mori et al., 1993). The RNA 3 molecule was chosen as the potential exists to 
insert two genes and still maintain the size of the original genome- fragment. It 
also exhibits a greater host range than BMV, thereby increasing its appeal as a 
broad host range expression vector. Once the efficacy of the vector had been 
demonstrated using reporter genes, the levels of expression of the L 1 protein 
could be compared to the constitutive levels in the transgenic plant. 
CHAPTER 2 
EXPRESSION OF HUMAN PAPILLOMAVIRUS MAJOR CAPSID 
PROTEIN IN TRANSGENIC TOBACCO 
INTRODUCTION. 
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The past decade has brought about large advances in plant tissue transformation 
techniques. It is now relatively simple to insert and express foreign genes in plant 
cells, which can subsequently be regenerated to mature plants capable of 
expressing the gene and passing it on to the next generation in a Mendelian 
fashion (Von Bodman et al., 1995). 
One of the most studied recent examples of the expression of a foreign antigen in 
transgenic plants has been the insertion of the gene encoding the hepatitis 8 
surface antigen (HBsAg) into tobacco plants {Mason et al., 1992). Partially 
purified HBsAg was used to immunise mice intraperitoneally (Thanavala et al., 
1995). Immunisation of mice with plant extract containing the antigen induced an 
immune response similar to the one obtained by immunising mice with yeast 
derived HBsAg (Thanavala et al., 1995). T-cells isolated from mice immunised 
with the tobacco-derived HBsAg could be stimulated in vitro with the yeast-derived 
antigen. These authors were able to conclusively prove that both the 8- and T-
eel! epitopes of the HBsAg were preserved in their transgenic plants. 
An example of the success of oral immunisation is found in a paper by Haq et al. 
(1995) where crude soluble extracts from transgenic tobacco and potato plants 
expressing the Escherichia coli heat-labile enterotoxin (L T-8) were used to 
immunise mice by gavage. Gavage entails force-feeding the mouse by means of a 
tube inserted down the oesophagus to the stomach. The mice developed both 
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serum and gut mucosa! anti-L T-B immunoglobulins that neutralised the 
enterotoxin in cell proliferation assays (Haq et al., 1995). 
Papillomaviruses are double stranded DNA viruses that cause cutaneous warts 
and mucosa! condylomata in a wide variety of animals. Human papillomaviruses 
(HPV) display specific tissue tropisms (Zur Hausen and De Villiers, 1994). 
Benign condylomata in the cervical mucosa often contain low-risk HPV types such 
as HPV-6 and HPV-11, whereas cervical carcinomas most frequently contain 
high-risk HPV types such as HPV-16 and HPV-18 (Cason et al., 1993; Hines et 
al., 1994). 
Antibodies generated in rabbits against the major capsid protein (L 1) of a virus 
related to HPV, cottontail rabbit papillomavirus (CRPV), provided the rabbits with 
protective immunity against subsequent infections with the wild type virus (Lin et 
al., 1992), despite low titres of neutralising antibodies. Similar results were 
obtained by a group working on bovine papillomavirus (BPV) L 1 protein 
inoculated into calves. ·These animals were able to generate serum neutralising 
antibodies to BPV when reinoculated with the BPV L 1 antigen (Jarrett et al., 1991; 
Campo et al., 1993). Breitburd et al. (1995) tested the ability of vaccination with 
virus-like particles (VLPs) ressembling CRPV to protect rabbits against papillomas 
induced by the wild type virus. None of the rabbits vaccinated with CRPV VLPs 
and subsequently challenged with CRPV particles developed cancer within 1 year 
of infection. No protection was however detected in rabbits vaccinated with native 
or denatured BPV L 1 or with denatured CRPV L 1. 
Both these studies indicate that the L 1 capsid protein of HPV could be important 
in the development of a vaccine for human papillomavirus. L 1 protein has been 
previously expressed in human cos cells under the control of the SV40 promoter. 
The recombinant L 1 protein was of the appropriate size (55kDa) and formed the 
correct conformational epitopes necessary for the formation of a neutralising 
antibody response (Ghim, et al., 1992). Kirnbauer et al. (1992) were able to 
express L 1 capsid protein of both BPV and HPV-16 in insect cells via a 
31 
baculovirus expression vector. The L 1 proteins were expressed to high levels 
and assembled into capsid-like particles. The self-assembled BPV L 1 was able to 
generate a higher titre of neutralising antibodies in rabbits than the L 1 extracted 
from recombinant bacteria. Hines et al. (1994) expanded on the strains tested by 
expressing the L 1 proteins of HPV-1, 6, 11 & 16 in both cos cells, under the SV40 
promoter and in a baculovirus expression system. The recombinant L 1 proteins 
also expressed conformational epitopes in both the cos and insect cells that were 
type specific and displayed neutralising epitopes (Hines et al., 1994). 
The success of plant-derived hepatitis B surface antigen and the heat labile 
enterotoxin of E. coli in providing a protective immune response after oral 
vaccination with the protein extracts containing the antigens is encouraging for 
the development of oral vaccines. We decided to try and express another antigen 
that holds promise as an oral immunogen: the L 1 capsid protein of HPV-16 
(Cason et al., 1993) in transgenic tobacco plants. Expression of L 1 protein in 
transgenic tobacco plants would give an indication of the basal level of expression 
in the plant. Once the viral vector had been successfully constructed, the gene 
encoding the L 1 protein could be inserted into the vector and the two levels of 
expression be compared. 
MATERIALS AND METHODS. 
DNA cloning procedures. 
pSK-L 1 was kindly donated by W. Burgers and Dr.A. Williamson (Medical Microbiology, 
University of Cape Town). The L 1 open reading frame was excised as a Clal/Xbal 
fragment and ligated into Clal/Xbal cut pART? as shown in figure 2.5 (Gleave, 1992). 
This placed the L 1 ORF downstream of the CaMV 358 promoter in the pART? primary 
cloning vector. The orientation of the insert was confirmed by restriction enzyme 
~malysis. The CaMV 35S promoter, L 1 ORF and ocs3' region (transcription termination 
region of the octopine synthase gene) cartridge was excised as a Natl fragment and 
ligated into Natl digested binary vector, pART27 (Gleave 1992). pART27 carries the RK2 
minimal replicon for maintainance in Agrobacterium, the ColE1 origin of replication for 
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high-copy maintainance in E. coli and the Tn7 spectinomycin/streptomycin resistance 
gene as selectable marker. The T-DNA of pART27 carries the kanamycin resistance 
gene which is expressed in both E. coli and Agrobacterium. The presence of the insert 
in pART27 was confirmed by restriction enzyme analysis. 
Agrobacterium transformation. 
Agrobacterium tumefaciens C58C1 (pMP90) was transformed with the L 1-pART27 clone 
by the freeze-thaw method of Hooykaas (1988). Agrobacterium was grown to an OD of 
0.4 in 5ml Luria broth containing gentamycin (40µg/ml) and rifampicin (100 µg/ml). All the 
following steps were done· on ice or at 4°C. The cells were centifuged at 3000g for 5 
minutes and resuspended in 1 ml ice-cold 20mM CaCl2. Aliquots of 0.1 ml were 
dispensed into precooled eppendorf tubes and 1 µg of plasmid DNA was added to the 
cells. The tube's were frozen in liquid nitrogen and then heat shocked at 37°C for 5 
minutes. 1 ml Luria broth was added to the transformed cells and they were then left to 
shake at 30°C for 4 hours. The cells were then plated onto Luria agar plates containing 
spectinomycin (100 µg/ml) and rifampicin (100 µg/ml). Agrobacterium transformants 
were obtained after 2 days growth at 30°C. The clones were checked for inserts by 
polymerase chain reaction utilising primers L 1 F (5'-CCCGGGATGT CTCTTTGGCT 
GCCTAG-3') and L 1R (5'-GCCTCGAGT TACAGCTTAC G f I I I I I GC-3') on samples 
picked from the plates with a plastic pipette tip. PCR reaction conditions were the same 
as in Appendix I except that the cycles were: .1 minute @ 93°C; 1 minute @ 55°C and 1 
minute @70°C for a total of 25 cycles. 
Plant transformations. 
Cut pieces of sterile N .. tabacum cv. Petit Havana SR1- were transformed with the 
modified Agrobacterium containing the L 1-protein gene as described by Horsch et al. 
(1985). Transformed calli were selected on regeneration medium supplemented with 
kanamycin at a concentration of 1 OOµg/ml. Resistant calli were induced to regenerate 
" shoots and roots, transferred to soil ~md maintained in a greenhouse (Horsch et al., 
1985). 
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a. b. 
Figure 2.1. Leaf transformations utilising Agrobacterium transformed with L 1-
pART27. (a) Untransformed leaf discs that are not kanamycin resistant. Leaf discs 
become pale and die off. (b) Transformed leaf discs showing callus formation. The 
untransformed sections of the leaf discs die off but the kanamycin resistent calli continue 
to proliferate. 
a. b. 
Figure 2.2. Plant regenerations. (a) Kanamycin resistant calli start to form shoots 30 
days after callus formation. (b) Shoots transferred to rooting medium containing 
kanamycin form roots after 4-7 days. 
I 
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DNA and RNA isolations from transformed plants. 
Both DNA and RNA were isolated from a 300mg leaf sample utilising the method of 
(Nelson, 1994). Briefly, the leaf was ground up in liquid nitrogen and 500µ1 of lysis buffer 
(100mM Tris-HCI, pH 8.6, 1% sarkosyl, 4M guanidium thiocyanate, 25mM EDTA pH 8, 
25mM EGT A pH 8, 100 mM p-mercaptoethoethanol) was added to the sample. 250µ1 
phenol was added and the sample shaken vigorously. 250µ1 chloroform was added, the 
sample was mixed well and centrifuged at 10 000 rpm for 10 minutes at 4°C. The SNF 
was once more extracted with phenol:chloroform. 1 µI of concentrated acetic acid was 
added to the SNF of the second extraction. 0.6 volumes of isopropanol was then added 
to the treated SNF and the samples were mixed and stored at -20°C for 2 hours. 
Samples were then allowed to thaw and were centrifuged at 4°C at 10 000 rpm for 10 
minutes.. The pellet was resuspended in 300µ1 DEPC-treated water containing 0.1 % 
SOS by pipetting up and down and incubating the tubes at 37°C for 10 minutes. The 
remaining insoluble material was removed by a brief centrifugation in the microfuge. 
The SNF was transferred to a new tube and 0.25 volumes of SM lithium chloride was 
added to the sample. The RNA was precipitated overnight at 4°C. The RNA was 
pelleted at 10 000 rpm for 30 minutes at 4°C and the SNF decanted to a fresh tube for 
DNA recovery. The RNA pellet was resuspended in 20µ1 of DEPC-treated water. 
The SNF from the RNA pelleting step was mixed with a 1/101h volume of 3M NaAc pH4.5 
and 2 volumes of 100% ethanol. Samples were left at -20°C for an hour before 
centrifugation at 10 000 rpm for 30 minutes at 4°C. The DNA pellet was washed in 70% 
ethanol and resuspended overnight in 20µ1 water. 
DIG-labelling of the L 1 DNA probe. 
pSKL 1 was .digested with Smal. The L 1 fragment was excised from a 1xTAE agarose 
gel stained with 0.02% methylene blue (Sambrook et al., 1989) and recovered utilising 
the Geneclean II Kit (BIO 101 Inc.). The fragment was labelled by random priming using 
DIG-labelled-dUTP as per Boehringer-Mannheim protocol. 
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PCR screening of L 1 transgenic plants. 
A 500ng amount of total plant DNA extracted above was used in a polymerase chain 
reaction to detect the L 1 gene. Reactions were done as in Appendix I utilising primers 
L 1 F and L 1 R and the cycling conditions used above. 
A volume of 1 OµI of each sample was loaded on a 1 % 1 xTBE agarose gel for 
electrophoresis as shown in figure 2.3 (Maniatis et al., 1989). The gel was blotted, 
probed with the L 1 DIG-labelled probe and detected as discussed in Appendix F (Fig 
2.3). 
Total protein isolations from L 1 transgenic plants. 
Leaf material weighing about 300mg was ground up in 400µ1 extraction buffer (0.25M 
Tris-HCI pH 7.8, 5mM EDTA, 1 % p-mercaptoethanol) and centrifuged at 4°C _for 15 
minutes. 350µ1 supernatant fluid containing soluble proteins was drawn off and stored at 
-20°C. 100µ1 2x disruption buffer (0.25M Tris-HCI pH 6.8, 30% v/v glycerol, 20% SOS, 
29% p-mercaptoethanol, 0.01 % w/v bromophenol blue) was added to the remaining SNF 
and pelleted debris. Samples were then boiled for 15 minutes and allowed to cool to 
room temperature. These samples contained both soluble and insoluble proteins. 
Western blot analysis of L 1 transgenic plants. 
A single well on an SDS-polyacrylamide gel (5% stacking gel and 12% resolving gel) was 
loaded with 50µ1 of the soluble and insoluble protein extr'3ction mix as per Sambrook et 
al. (1989). Recombinant L 1 protein obtained from a baculovirus expression system was 
used as a positive control (Rose et al., 1994). The proteins were transferred to a nitro-
. cellulose membrane using a horizontal blotting apparatus with carbon electrodes. The 
Boehringer-Mannheim Western Blotting Kit was used to detect L 1 protein on the 
membranes. Rabbit anti-bovine papillomavirus antiserum (DAKO) was used as the 
primary antibody at a 1/100 dilution. 
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RESULTS 
L 1 TRANSFORMATION OF AGROBACTERIUM. 
The L 1 gene encoding the major capsid protein of HPV-16 was cloned into the 
binary vector pART27. This clone was used to transform Agrobacterium 
tumefaciens C58C1 (pMP90). The resultant transformants were screened by PCR 
as well as by restriction enzyme analysis (results not shown). 
L 1 TRANSFORMATION OF TOBACCO PLANTS. 
N. tabacum cv. Petit Havana SR1 leaf discs were successfully transformed by the 
L 1-Agrobacterium. Kanamycin resistant calli were observed 30 days after 
incubation with the bacterium (Fig. 2.1 ). Shoots appeared after another 30 days 
and were transferred to rooting medium 20 days later (Fig. 2.2). Samples were 
taken for DNA and protein analysis after another 2 months on kanamycin 
containing medium (1 OO~Lg/ml). 
PCR SCREENING OF L 1 TRANSGENIC PLANTS. 
A total of 19 kanamycin resistant plants were screened of which 17 were PCR 
positive for the L 1 gene using L 1 specific primers (Fig.2.3). Transgenic positive 
plants gave a product of 1.6kb, the same size as the product obtained from pSK-
L 1 positive control. Probing with a DIG-labelled L 1 DNA probe confirmed that the 
two negative plants contained no L 1 gene and that the PCR fragments were 
indeed the L 1 amplified gene (Fig.2.3). 
WESTERN BLOT ANALYSIS OF L 1 TRANSGENIC PLANTS. 
A volume of 25µ1 total protein extract, representing about 50µg protein of each 
. plant was loaded onto a protein gel. 250ng of recombinant L 1 protein (Rose et 
al., 1994) was loaded onto each gel as a positive control. Each gel also carried a 
a. 
b. 
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Figure 2.3. PCR analysis of L 1 transgenic plants. 
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(a) Lane 1: A.·DNA cut with Pstl as molecular weight markers. The sizes of the relevant 
fragments are given in kilobases beside the gel. Lane 2-11: Transgenic plants numbers 
2, 3, 5, 8, 9, 11, 12, 14, 15 & 16. Only plant# 12 does not carry the L1 gene on this gel. 
Lane 12: PCR positive control on 100ng pSK-L 1. Lane 13: PCR negative control on a 
non-transgenic tobacco plant DNA sample. (b) Southern blot result of the PCR gel 
probed with the DIG-labelled L 1 probe. Lanes as above with Lane 2 corresponding to 
transgenic plant #2. 
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non- transgenic plant protein extract as a negative control. Proteins were 
transferred to nitrocellulose membranes and incubated with antibody to disrupted 
BPV. The results of the Western blot are presented in figure 2.4. The L 1 
positive control did not light up which suggests that the detection system is at 
fault. No bands were observed at 55kDa which is where L 1 is expected to band 
(Kirnbauer et al., 1992). Any bands observed in this region after longer exposure 
times were also visible in the plant negative control protein extracts. 
a. 
3 4 5 6 7 8 9 10 
69-
46-
30-
Figure 2.4. Western blot analysis of L 1 transgenic plants. (a} Lane 1: Rainbow 
molecular weight markers (Amersham Life Sciences} Protein sizes are indicated in kDa. 
Lane 2: 250ng recombinant L 1 protein; lane 3: transgenic negative plant protein extract; 
lanes 4-10: protein extracts #2, 3, 5, 8, 9, 14 & 15 from plants that were PCR positive for 
the L 1 gene. 
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Figure 2.5. Construction of the plant transformation vector L 1-pART27. The L1 
gene was cloned as a Clal/Xbal fragment into the Clal and Xbal sites of the multiple cloning site of 
vector pART7, placing the gene downstream of the cauliflower mosaic virus 35S promoter 
(CaMV35S) and upstream of the transcription termination region of the octopine synthase gene 
(ocs3'). This region was excised as a Notl fragment from pART7 and inserted into pART27 at the 
Notl site, within the /acZ region (encoding the lac a.peptide) indicated by the coloured arrowed box. 
The right border (RB) and left border (LB) are indicated by clear arrowed boxes. The chimaeric 
nptll gene provides kanamycin resistance in both E. coli and Agrobacterium. SpR/StR is the 
bacterial selectable marker for spectinomycin/streptomycin resistance. oriT is the RK2 origen of 
transfer and the ColE1 allows for replication in E. coli. 
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DISCUSSION. 
In order to detect L 1 protein in total protein leaf extracts from leaves, a suitable 
antiserum is required. Antibodies to BPV have ppreviously been show to cross-
react with denatured HPV-16 L 1 protein (Hines et al., 1994). The commercial 
antibodies used in this study were also made to target disrupted BPV and so 
should have recognised the disrupted, plant produced HPV-16 L 1 antigen. The 
fact that the anti-BPV serum could not detect the L 1 recombinant positive control 
protein would suggest that there is a problem with the antiserum and a new 
antiserum may give a better result. The colleagues (Di Marais and Dr. A. 
Williamson, Medical Microbiology, University of Cape Town) who provided the 
Rose (1994) recombinant L 1 antigen have subsequently been unable to show 
that it reacts with L 1 antiserum, indicating that the positive control antigen may be 
at fault. It was therefore imperative to demonstrate the presence of L 1 specific 
RNA in plant total RNA preparations and also the integration of the L 1 gene into 
the genome of the tobacco plant. 
Northern blots were attempted to determine whether the L 1 gene was being 
expressed, but the results were inconclusive. These blots need to be repeated 
once more plant material becomes available. If certain plants do show expression 
of L 1 protein, immunohistochemistry could be done on sections of leaf material to 
determine whether virus-like particles are being formed in the leaf tissue. 
In conclusion, 19 kanamycin resistant plants were regenerated of which 17 have 
been shown to carry the L 1 gene in their genetic make-up (Fig. 2.3). Ideally one 
should do a Southern blot to determine whether the gene is integrated into the 
plant genome once more plant tissue is available to do a large scale DNA 
extraction. We were unable to show whether the L 1 gene was being expressed 
and could not detect whether the L 1 protein was present in total protein extracts 
or not. Further analysis of these plants may yield some tnteresting and insightful 
results as to the production of viral antigens in plants. 
CHAPTER3 
MOLECULAR CC.ONING OF THE 5' AND 3' UNTRANSLATED 
REGIONS OF CUCUMBER MOSAIC VIRUS RNA 3. 
INTRODUCTION 
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Recombinant DNA technology has made it possible to analyse viral genomes at the 
molecular level and study the effects of genetic modifications on their organisation 
and expression. Studies on RNA virus genomes have previously been hampered by 
the fact that these viruses do not utilise a DNA intermediate during replication, 
making investigations of their life cycles difficult. The possibility of obtaining 
infectious cDNA clones of plus-strand RNA virus genomes has since provided 
extensive information on replication and movement of these viruses (Boyer and 
Haenni, 1994). Moreover, these clones can be utilised to construct infectious 
satellite RNAs for expression of foreign proteins in plants (Donson et al., 1991; 
Hamamoto et al., 1993; Kumagai et al., 1993 & Mori et al., 1993). 
We chose to investigate the potential of cucumber mosaic virus (CMV), as a plant 
expression vector. CMV has a much broader host range than BMV, another member 
of the Bromoviridae previously used in plant viral vector studies (Mori et al. 1991 ). 
CMV infects both monocot and dicot plants, thereby increasing its appeal as a broad 
host range plant expression vector. The replication functions would be provided to 
the satellite RNA by co-inoculation of the plants with total infectious CMV RNA 
extracts from wild type infected plants (Fig 3.1 ). This procedure would provide us 
. with a rapid means of testing the system without having to construct full-length cDNA 
copies of RNAs 1 & 2. 
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CMV 
FOREIGN GENE + 
Inoculate 
Figure 3.1. Representation of the strategy to express a foreign protein in plants. 
A viral-like RNA carrying the gene of interest would be co-inoculated with wild type CMV RNA onto 
healthy plants and monitored for the production of the foreign protein. 
The construction of a full length cDNA clone is a long and tedious process. 
Generally, the entire sequence is required to produce infectious clones, but 
infectious transcripts have been produced using incomplete viral cDNA clones (Davis 
et al., 1989). The presence of non-viral nucleotides at the 5' end of infectious 
transcripts strongly reduces infectivity (Janda et al., 1987). 3' non-viral extensions 
do not appear to interfere with viral replication provided the secondary structure of 
the 3' terminus is not abrogated (Miller et al., 1986). 
This chapter describes the cloning and sequencing of the 5' and 3' untranslated 
regions (UTR) of CMV Y and the insertion of a reporter gene between them to create 
plasmid p5'cat3'. 
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MATERIALS AND METHODS. 
Virus strains. 
CMV-Y was kindly donated for initial studies by Prof. M.B. van Wechmar. This isolate 
originally was characterised by the late R.LB. Francki and is a subgroup I CMV member 
(Palukaitis et al., 1992). CMV Y was propagated on Nicotiana glutinosa plants. 
Viral double stranded RNA extraction. 
Double stranded CMV-Y RNA was isolated from infected Nicotiana tabacum cv xanthi 
plants according to the method of Valverde (1990). 5g leaf tissue was ground to a fine 
powder in liquid nitrogen and added to 8 ml 1xSTE buffer (pH 6.8) in a 50 ml centrifuge 
tube. 1 ml of 10% SOS, 0.5 ml 2% bentonite and 9 ml of STE saturated phenol was added 
to the homogenate and the tubes were shaken thoroughly for 30 minutes. · After 
centrifugation at 8000 g for 15 min.(Sorval RC-5 Superspeed), the supernatant fluid (SNF) 
was transferred to a new 50 ml centrifuge tube and its ethanol concentration adjusted to 
16% v/v. SNF was then passed through a cellulose column and then washed with 40 ml 
1xSTE containing ethanol at 16% v/v. The ds RNA was eluted by first equilibrating the 
column with 2.5 ml 1xSTE and washing it out with 10 ml 1x STE. The sample was collected 
in a 50 ml centrifuge tube, again made up to 16% ethanol v/v and passed through a second 
cellulose column. This time the sample was eluted in 6ml 1 x STE and collected in a new 50 
ml centrifuge tube. RNA was precipitated by adding 0.5 ml 3M sodium acetate (pH 5.5) and 
20 ml 95% ethanol to the sample and storing it at -20°C overnight. Samples were 
centrifuged at 8000 g for 30 minutes, the pellets washed in 70% ethanol at -20°C and 
resuspended in 100µ11xTE and stored indefinitely at 4°C. 
Complementary DNA synthesis. 
Four synthetic oligonucleotides were designed based on the previously published sequence 
of CMV Y (Prof. Rybicki, Microbiology, University of Cape Town). Both oligonucleotides 
5vec4 (5'-CCCTCGAGGT AATCTAACCA CCTGTG-3') and 5vec5 (5'-CCCTCGAGGC 
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CTCGGGAAAT CTAAC-3') were used to initiate first strand cDNA synthesis of the 5' UTR. 
Two strands of cDNA were synthesised from the ds RNA template used in the reverse 
transcription reaction (Appendix H). The same primers were used in the ensuing 
amplification step (Appendix I). Both these primers incorporated an Xho I restriction 
enzyme site at their 5' ends to facilitate easy cloning of the cDNA fragment. 
Oligonucleotides 3vec4 (5'-CCGGATCCTT CCCAGAATCC TCCCT-3') and 3vec3a (5'-
TGGAGGCCCC CACGAAG-3') were used similarly to obtain a cDNA copy of the 3' UTR. 
This product had to be amplified a second time with the overlapping 3vec3 oligo (5'-
CCGAGCTCTG GTCTCCTTTT GGAGG-3') to produce a full length 311 bp fragment of the 
3' UTR. Primer 3vec3 included a Sac I restriction enzyme site at its 5' end while 3vec4 
carried a Barn HI site at its 5' end to ease the cloning process. Table 3.1 lists the primer 
sequences as well as the restriction sites found on each. Figure 3.4 illustrates the PCR 
strategy employed to amplify the UTRs. 
Primer RE site* Primer sequence 
5vec4 Xhol 5' -CCCTCGAGGT AA TCT AACCAC CTGTG-3' 
5vec5 Xhol 5'-CCCTCGAGGCCTCGGGAAA TCT AAC-3' q 
3vec4 BamHI 5' -CCGGATCCTTCCCAGAA TCCTCCCT-3' 
3vec3a none 5' -TGGAGGCCCCCACGAAG 
3vec3 Sac I 5'- CCGAGCTCTGGTCTCCTTTTGGAGG-3' 
Table 3.1. Table showing the primers used to amplify the 5'- and 3'-UTRs of CMV Y. 
The sequences of the restriction enzyme sites included in some of the primers are underlined. The 
PCR strategy is illustrated in figure 3.4. • RE site: restriction enzyme site. Bold bases indicate the 6 
base pair overlap between primers 3vec3a and 3vec3. 
Attempts were made to obtain a full length cDNA copy of the entire RNA 3 molecule using 
oligonucleotides 5vec4 and 3vec3a. First attempts were done similarly to the 5' and 3' UTRs 
(Appendix I) except that the extension time at 72°C in the amplification stage was increased 
to 180 seconds. Later attempts tried different denaturing conditions, different reverse 
transcriptase enzymes: Tth polymerase (Boehringer-Mannheim); AMV (Promega) and 
MMuLV (Promega) and varying amplification conditions. 
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Complementary DNA cloning. 
pCMVS'. 
Double stranded DNA of the 5' end was blunted (Appendix Jii) and inserted into Xhol 
digested and blunted pSK vector (Appendix Ji & iii). This clone contained an extra aberrant 
amplification fragment of 90 base pairs. The required 132 bp fragment was excised from 
this clone by utilising the Xhol sites in the oligonucleotides used to amplify the 5' cDNA 
fragment. The gel-purified 5' Xhol fragment was inserted into the pKS Xho I site to yield 
pCMV5' (Fig. 3.45. which was subsequently transformed into competent E.coli Dh5a. cells 
and sequenced (Appendix Jiv). 
pCMV3'. 
This clone was constructed by inserting the 3' ds cDNA fragment into Smal cut and alkaline 
phosphatase treated pSK (Fig. 3.5) as described in appendix J. This clone was transformed 
into competent E.coli Dh5a. cells and sequenced (Appendix Jiv & 0). 
p5'cat3'. 
The 3' UTR was excised from pCMV3' using the BamHl/Sacl primer sites and directionally 
cloned into BamHl/Sacl digested pCMV5' to yield clone pCMV5'3' (Fig. 3.5). 
Oligonucleotides 5vec4 and 3vec3 were used in an amplification reaction to confirm the 
orientation of the 3' insert. 
The cat gene conferring resistance to the antibiotic chloramphenicol was excised from pCm1 
as a Taql fragment and inserted into the Clal site of pCMV5'3' to render p5'cat3' (Fig. 3.5). 
The orientation of the insert was confirmed by restriction enzyme analysis and end-
sequencing across the 5' UTR. 
Double stranded RNA infectivity studies. 
Double stranded RNA of CMV-Y was heat denatured at 80°C for 1 O minutes in a 50% 
DMSO solution and then placed on ice until inoculation. Denatured ds RNA was inoculated 
onto 4 celite dusted leaves of Nicotiana g/utinosa plants at a concentration of 75µg/ml in a 
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1 % bentonite solution. Control plants were similarly inoculated with non-denatured ds RNA. 
Plants were monitored for symptom development for 22 days post inoculation. 
RESULTS: 
Double stranded RNA isolations and infectivity studies. 
Double stranded RNA was successfully isolated from CMV-linfected Nicotiana 
tabacum cv. xanthi plants as shown in figure 3.2. 
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Figure 3.2 Double stranded RNA profile of CMV Y. Lane 1: A.-DNA cut with Pstl. The 
sizes of the fragments are indicated in kilobases; Lane 2: CMV-Y dsRNA. 
Four plants inoculated with denatured ds RNA exhibited slight mosaic symptoms 
three days post inoculation (p.i. ) and severe mosaic patterns by day 8 p.i. Control 
plants showed no symptom development 22 day p.i (results not shown). This clearly 
demonstrated that fully denatured ds RNA of CMV-Y is infectious. 
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Reverse transcription and cDNA synthesis. 
The extensive secondary structure found in the 5' and 3' UTRs (Figures 3.8 & 3.9) 
make reverse transcr!ption (RT) and amplification very difficult. Both UTR fragments 
were obtained by extensively denaturing the ds RNA template in 10% DMSO and 
doing the RT reaction (Appendix H) at 70°C using a thermostable polymerase, Tth 
which also has reverse transcriptase activity in the presence of manganese 
(Boehringer-Mannheim). The cDNA was then amplified (Appendix I) by PCR with the 
necessary primers to give ds DNA fragments of each UTR (Fig. 3.4). The 5'-UTR 
was made using primers Svec4 and 5vec5 for both the RT and PCR reactions 
(Appendix H & I). The 3' -UTR was reverse transcribed using primers 3vec4 and 
3vec3a. Primer . 3vec3, complementary to the 3' end of CMV Y, was unable to bind 
the template RNA during RT so another overlapping primer (Table 3.1 ), primer 
3vec3a, was designed with less secondary structure than 3vec3. This primer yielded 
a slightly shortened 3'-UTR fragment after RT-PCR. The full-length 3' fragment (311 
bp) was obtained by a second round of PCR using the 3vec3 primer (Fig. 3.4). PCR 
fragments were analysed on a 2% agarose gel (Appendix E) as shown in figure 3.3. 
450-
340-
250-
216 & 211. 
200 f 
164-
150 f 
+:.311 
+-135 
Figure 3.3. PCR amplification of the 5' and 3' untranslated regions. Lane 1: A. ONA cut 
with Pstl. (the sizes of the bands are indicated in base pairs; lanes 2&3: 135 bp PCR fragment of the 
S'UTR; lane 4: Control PCR RT-PCR with primers 5vec4 and 5vec5; lanes 5&6: 311 bp PCR fragment 
of the 3'UTR; lane 7: Control RT-PCR with primers 3vec3 and 3vec4. 
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Several attempts at obtaining a full-length cDNA clone of the entire CMV RNA 3 were 
unsuccessful. Neither increasing the DMSO concentration to 50% to fully denature 
the ds RNA, nor extending the extension times could solve the problem. MuMLV 
J 
reverse transcriptase (Promega) and AMV reverse transcriptase (Promega) were 
used according to the manufacturers instructions, but no product was obtained. 
CMV RNA3 
5'UTR 
PCR 
PRIMERS: 5vec4 5vec5 
IGR 
3vec4 
31 UTR 
3vec3 
3vec3a 
Figure 3.4. Diagram illustrating the PCR strategy for the amplification of the 5' & 3' 
UTRs as well as full-length RNA 3. A full description of each primer is given in table 3.1. 
cDNA cloning and sequence analysis of: 
The 5' UTR. 
The 5' UTR (135 bp) was cloned into the Xhol site of pKS to give clone pCMV5' (Fig 
3.5). The sequence varied from the published sequence of CMV Y at a few 
positions: a GC insertion at base 23 ; an A to G change at position 34; a G to A at 
position 51; a T to C at position 67; a deletion of an A at position 81; a change of an 
A to a T at position 83; a change of a T to an A at base 85; an A to C change at base 
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87 and the sequence at base 91 was altered from CGTT to ATGT. These variations 
in the sequence of the 5' UTR of CMV Y were found to occur in other subgroup I 
CMVs; the sequence of CMV Fny (Owen et al., 1990) is shown in figure 3.6 for 
comparison. 
BamHl/Sa~ 
= = ~ a: -
"E-"Ess_,,, 
·- ..!!! ·- 1ii E ::c:o::c:wwa..w 
I J l I 
pCMV5'3' 
____ ,,,., 
:I: 
E o 
I'll I'll 
p5'CAT3' 
Figure 3.5. Diagram illustrating the cloning procedure to create p5'cat3'. 
5': 5' untranslated region; 3': 3' untranslated region; CAT: chloramphenicol acetyl transferase gene 
Taql fragment from pCm1; lac: arrow indicates the direction of the ~-galactosidase gene. A more 
extensive description of the cloning strategy is given in the Materials and Methods section. 
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The 3'UTR. 
The 3' UTR was cloned into Smal cut pKS and the clone pCMV3' was subsequently 
sequenced. The 3' terminus was more conserved with only two changes being 
observed: an insertion of a T at position 2003 and a change of a T to a C at position 
2065 of CMV Y. The deletion does not fall within the essential 3' tRNA-like region of 
the 3' UTR (Fig. 3.9) and the T to C change occurs in other strains of CMV; the 
sequence of CMV Fny is shown in figure 3. 7 for comparison. 
pCMV5'cat3'. 
pCMV5'3' (Fig.3.5) was constructed by inserting the 3'-UTR downstream of the 5'-
UTR in pCMV5'. The construct was checked by restriction enzyme analysis and 
chain reaction using the 5vec4 and 3vec3 primers (Fig 3.4).The cloning procedure 
created a mini-multiple cloning site (MCS) between the 5'- and 3'-UTRs which would 
facilitate the insertion of a foreign gene between them. The E. coli chloramphenicol 
acetyl transferase (CAT) gene was cloned as a Taql fragment into the Clal site in this 
mini-MCS. The CAT gene was obtained from pCM1 growing on CAT 100µg/ml. 
Sequencing of the clone p5'cat3' (Fig. 3.5) showed that the CAT gene was inserted 
in the correct orientation. Restriction enzyme analysis and PCR amplification using 
the 5vec4 and 3vec3 primers revealed no deletions in the initial p5'3' clone as result 
of this cloning step (results not shown). 
CLUSTAL W(l.5) multiple sequence alignment 
CmvSpr 
CmvfnyS 
CmvyS 
CmvSpr 
CmvfnyS 
CmvyS 
CmvSpr 
CmvfnyS 
CmvyS 
CTCGAGGTAATCTAACCACCTGTGTGTGTGCGTGTGTGTGTGTCGAGTCGTGTTGTCC 
--------GTAATCTTACCA-CTGTGTGTGTGCGTGTGTGTGTGTCGAGTCGTGTTGTCC 
--------GTAATCTAACCACCTGTGTGTGT--GTGTGTGTGTATCGAGTCGTGTTGTCC 
••••••• •••• •••••••••• • ••••••••••••••••••••••••• 
ACACATTTGAGTCGTGCTGTCCGCACATAT-TTTATCTTTATGTGTACAGTGTGTTAGAT 
GCACATTTGAGTCGTGCTGTCCGCACATAT-TTTATCTTT-TGGGTACAGTGTGTTAGAT 
GCACATTTGAGTCGTGTTGTCCGCACATATATATTTATTTCGTTGTACAGTGTGTTAGAT 
••••••••••••••••••••••••••••••• *** 
TTCCGAGCCTCGAGGG 
TTCC------------
TTCC------------
**** 
•••••••••••••••• 
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Figure 3.6. Sequence comparison of the S'UTR with CMV Y (Nitta et al., 1988) and 
another subgroup I CMV strain, CMV Fny (Owen et al., 1990). Cmv5pr; S'UTR of the 
strain of CMV Y used in this study; Cmvy5: S'UTR of CMV Y (Nitta et al., 1988): 
Cmvfny5: S'UTR of CMV Fny (Owen et al., 1990). Extra base pairs in CmvSpr are 
from restriction enzyme sites incorporated into the primers used to amplify the S'UTR. 
CLUSTAL W(l.5) multiple sequence alignment 
Cmv3pr 
Cmvy3 
Cmvfny3 
Cmv3pr 
Cmvy3 
Cmvf ny3 
Cmv3pr 
Cmvy3 
Cmvfny3 
Cmv3pr 
Cmvy3 
Cmvfny3 
Cmv3pr 
Cmvy3 
Cmvfny3 
Cmv3pr 
Cmvy3 
Cmvfny3 
CCGGATCCTTCCCAGAATCCTCCCTCCGATCTCTGTGGCGGGAGCTGAGTTGGCAGTTCT 
--------TTCCCAGAATCCTCCCTCCGATCTCTGTGGCGGGAGCTGAGTTGGCAGTTCT 
--------TTCCCAGAATCCTCCCTCCGATCTCTGTGGCGGGACGTGAGTTGGCAGTTCT 
*********************************** *************** 
GCTATAAACTGTCTGAAGTCACTAAACG-TTTTTACGGTGAACGGGTTGTCCATCCAGCT 
GCTATAAACTGTCTGAAGTCACTAAACG--TTTTACGGTGAACGGGTTGTCCATCCAGCT 
GCTATAAACTGTCTGAAGTCACTAAACGTTTTTTACGGTGAACGGGTTGTCCATCCAGCT 
**************************** ****************************** 
TACGGCTAAAATGGTCAGTCGTGGAGAAATCCACGCCAGCAGATTTACAAATCTCTGAGG 
TACGGCTAAAATGGTCAGTCGTGGAGAAATCTACGCCAGCAGATTTACAAATCTCTGAGG 
TACGGCTAAAATGGTCAGTCGTGGAGAAATCCACGCCAGCAGATTTACAAATCTCTGAGG 
******************************* **************************** 
CGCCTTTGAAACCATCTCCTAGGTTTCTTCGGAAGGACTTCGGTCCGTGTACCTCTAGCA 
CGCCTTTGAAACCATCTCCTAGGTTTCTTCGGAAGGACTTCGGTCCGTGTACCTCTAGCA 
CGCCTTTGAAACCATCTCCTAGGTTTCTTCGGAAGGACTTCGGTCCGTGTACCTCTAGCA 
************************************************************ 
CAACGTGCTAGTTTCAGGGTACGGGTGCCCCCCCACCTTCGTGGGGGCCTCCAAAAGGAG 
CAACGTGCTAGTTTCAGGGTACGGGTGCCCCCCCACCTTCGTGGGGGCCTCCAAAAGGAG 
CAACGTGCTAGTTTCAGGGTACGGGTGCCCCCCCACTTTCGTGGGGGCCTCCAAAAGGAG 
************************************ *********************** 
ACCAGAGCTCGG 
ACCA--------
ACCA--------
**** 
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Figure 3.7. Sequence comparison of_the 3'UTR with CMV Y (Nitta et al., 1988) and 
another subgroup I CMV strain, CMV Fny (Owen et al., 1990). Cmv3pr; 3'UTR of the 
strain of CMV Y used in this study; Cmvy3: 3'UTR of CMV Y (Nitta et al., 1988): 
Cmvfny3: 3'UTR of CMV Fny (Owen et al., 1990). Extra base pairs in Cmv3pr are 
from restriction enzyme sites incorporated into the primers used to amplify the 3'UTR. 
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A. 
.. 
8. 
. 
Figure 3.8. A comparison of the secondary structures of the S'UTR of: A the 
published CMV Y strain (Nitta et al., 1988) and B: The CMV Y strain variant used in 
this study. The program Squiggles was used to generate these representations from 
the Fold programme of the GCG Wisconsin sequence analysis package. 
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A. 
.. 
8. 
Figure 3.9. A comparison of the secondary structures of the 3'UTR of: A the 
published CMV Y strain (Nitta et al., 1988) and B: The CMV Y strain variant used in 
this study. The program Squiggles was used to generate these representations from 
the Fold programme of the GCG Wisconsin sequence analysis package. 
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DISCUSSION. 
The inability to make a full-length cDNA copy of the RNA 3 of CMV Y was problematic. The 
initial aim was to create a full-length cDNA from which a biologically active RNA 3 could be 
transcribed, the intention being to test the infectivity of the RNA 3 transcript by providing the 
replication functions in the form of fully denatured, gel purified ds RNA 1 & 2. The infectivity 
studies done on fully denatured double stranded RNA clearly showed that this form of 
CMV Y is fully infectious. The fully functional 5' and 3' UTRs would then have been excised 
from the infectious RNA 3 cDNA clone for construction of the expression vector. Several 
attempts using previously tried and tested protocols proved ineffective. A possible 
explanation could be that the ds RNA was not fully denatured, thereby stalling the reverse 
transcriptase in its first strand synthesis. Treating the ds RNA with methyl-mercuric 
hydroxide (Dawson et al., 1986) to fully denature the RNA before RT PCR may obviate the 
problem. Another option is to utilise inner primers that will amplify an overlapping section of 
the RNA which also contains a unique restriction enzyme site. This site could be used to 
ligate the two shorter cDNA fragments of RNA 3 to create a full-length clone (Suzuki et al., 
1991). 
The 5'- and 3'-UTRs that had been obtained directly from the ds RNA isolated from CMV Y 
were subsequently used to construct the viral vector without first being able to test their 
biological activities. The sequence analysis would suggest that these clones were fully 
functional, showing no serious deletions or changes in secondary structure (Figures 3.8 and 
3.9). 
Denatured ds RNA fom CMV-Y was shown to be fully infectious on tobacco plants. This 
result is novel as far as we know, as ds RNAs of ss RNA plant viruses have hitherto been 
thought to be non-infectious. The success of this experiment would suggest that RNA 
viruses could be stored and transported in the ds RNA form which is more stable than intact 
virions containing ss genomic RNA (Rybicki, 1995). The possibility of escape of the virus 
during transport is also reduced, as ds RNA needs to be fully denatured before it is 
infectious. 
CHAPTER 4 
CONSTRUCTION AND TESTING OF THE RNA & DNA 
EXPRESSION VECTORS CONTAINING THE CLONED CMV 
FRAGMENTS. 
INTRODUCTION. 
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The creation of a viral expression vector is a logical progression from making 
infectious clones corresponding to the genomes of RNA viruses, which can be 
expressed in the plant either as infectious cDNA or as in vitro-transcribed RNA 
Both techniques will be reviewed below. 
IN PLANTA TRANSCRIBED RNA. 
The first approach to expressing in vitro synthesised RNA in plants entails cloning 
the viral sequence downstream of the CaMV 35S promoter (Mori et al., 1991; 
Dessens & Lomonossoff, 1993; Macfarlane et al., 1992; Ding et al., 1995). The 
DNA clone is inoculated onto the plant where it is targeted to the plant cell 
nucleus. The host transcription mechanism recognises the viral CaMV 35S or 
other plant promoter and makes mRNA from the DNA clone (Fig. 4.1 ). The mRNA 
is exported to the cytoplasm where it is translated to produce the relevant viral 
proteins (Van Bokhoven et al., 1993) necessary for the normal viral life cycle in 
the host. 
A full length cDNA copy of the viral RNA genome can be usually produced by 
reverse transcription utilising a primer complementary to the sequence at the 3'-
0H end of the molecule. The ssDNA can then be made double stranded and 
amplified by PCR utilising a second primer complementary to the 5' end of the 
viral genome (Dessens & Lomonossof, 1993). These authors were also able to 
demonstrate that a polyadenylation signal is not required for the viral RNA to be 
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exported from the nucleus and translated in the cytoplasm: they inoculated cloned 
cDNAs of cowpea mosaic virus (CPMV) RNAs 1 & 2 onto cowpea seedlings, with 
the plasmid DNA linearised immediately after the viral 3' end, thereby preventing 
the synthesis of transcripts longer than genome-length. No CPMV symptoms 
were formed on cowpea plants inoculated with equal amounts of non-linearised 
plasmid DNA, confirming the importance of preventing the synthesis of over-sized 
transcripts (Dessens & Lomonosoff, 1993). 
Yamaya et al. (1988) were able to express TMV RNA in transgenic plants 
generated by agroinfection with Agrobacterium tumefaciens expressing the viral 
sequence. They placed the viral cDNA sequences under the control of the CaMV 
35S promoter in a specially designed plasmid vector. The CaMV 35S promoter 
was modified so that the 5' end of the in vivo transcripts would coincide with the 5' 
end of the viral RNA, without incorporating any extra non-viral nucleotides, 
thereby generating an RNA that resembled the true viral genomic RNA. 
A contrary result has been demonstrated by Commandeur et al. (1991) for barley 
yellow dwarf virus (BYDV). cDNAs of BYDV RNAs 3 & 4 that were cloned 
between the CaMV 35 S promoter and a polyadenylation signal sequence, were 
found to be biologically active despite having extra non-viral nucleotides at their 5' 
and 3' ends. The extra nucleotides - up to 40 at the 5' end (only 15 extra were 
tolerated on RNA 3) and several hundred at the 3' end - were not included in the 
sequence of the in vivo produced transcripts. 
There are cases of vrral RNAs being synthesised from cDNAs lacking RNA 
polymerase sequences as was found with a cDNA copy of AIMV RNA3 (Dore & 
Pinck, 1988). It is thought that the promoter activity could be provided by "cryptic 
promoter-like" sites on the DNA or by integration into the host cell genome, 
downstream of an active promoter (Boyer & Haenni, 1994). 
The expression of infectious viral RNAs through in vivo transcription of cDNA-
containing vectors has several advantages. DNA is more stable than RNA and 
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therefore less likely to be degraded in the inoculum. The expense and technical 
difficulties of RNA transcription and capping are also circumvented by using cDNA 
clones of viruses (Ding et al., 1995). Transcripts are also continuously provided 
from the cDNA in the nl:J.cleus of the inoculated cells (Mori et al., 1991) to the 
cytoplasm for inclusion in the viral replication cycle. 
IN VITRO TRANSCRIBED RNA. 
Infectious viral RNA can be transcribed in vitro from a cDNA clone placed 
downstream of a T7 phage promoter using T7 RNA polymerase. These run-off 
RNA transcripts are then inoculated onto plants which are monitored for symptom 
development as illustrated in figure 4.1. This has been done successfully for 
CMV (Hayes & Buck, 1990b; Suzuki et al., 1991 and Boccard and Baulcombe, 
1992) as well as BMV (Ahlquist et al., 1987; Mori et al., 1991; Mori et al., 1993), 
TMV (Dawson et al., 1986; Donson et al 1991; Hamamoto et al., 1993), alfalfa 
mosaic virus (Van der Vossen et al., 1993.) and BBMV (Pogany et al., 1994). 
The first transcription vector designed by Ahlquist et al. (1984) allowed the 
insertion of a viral cDNA sequences downstream of a bacteriophage >..-promoter. 
E. coli RNA polymerase was used in the in vitro transcription reactions to make 
infectious RNA transcripts. There were a couple of disadvantages of the E. coli 
RNA polymerase based system: the polymerase produced a large proportion of 
premature termination products which resulted in lower than expected yields of 
transcript, and the commercially obtained E. coli RNA polymerases were also 
subject to great batch variability. The T7 RNA polymera-se promoter sequence is 
preferred in the construction of cDNA clones for RNA transcription as T7 RNA 
polymerase gives much higher yields of transcript and its level of activity is 
maintained between different batches of the enzyme (Ahlquist et al., 1987; Boyer 
& Haenni, 1994). 
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Figure 4.1 Diagram illustrating the inoculation strategy of the artificially produced RNA and 
cDNA copies of the viral RNAs onto plants to produce infectious virions. 
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An oligonucleotide containing the T7 promoter sequence directly linked to the 5' -
end nucleotides of the viral sequence can be used to prime second strand 
synthesis of the viral cDNA. This procedure ensures the promoter is fused to the 
5' end of the viral sequence without the incorporation of extra non-viral 
nucleotides. The aim of the cloning process is to obtain RNA transcripts 
resembling the wild type RNA as closely as possible, as previous studies have 
demonstrated that addition of 5' non-viral nucleotides or interference with the 3' 
end secondary structure interferes with viral infection efficiency (Miller et al. , 
1986; Janda et al., 1987). 
The advantage of this approach is that one does not need to have cDNA copies of 
all the viral genome segments in order to study the segment of interest. The other 
segments needed for infection can be supplied from a total RNA extraction from a 
plant infected with the wild type virus. The wild type RNA would then support the 
replication of the transcribed viral RNA segment. The RNA is immediately able to 
be expressed and produce the protein of interest. The disadvantages are that the 
inoculum RNA is easily degraded and vast quantities are required for successful 
inoculations. - Preparation of RNA transcripts is very labour intensive as all 
procedures must be done in an RNase free environment and the transcripts also 
have to be capped with 7-methyl guanosine to be biologically active in the plant 
cell. 
This chapter describes the construction and subsequent testing of both DNA and 
RNA versions of the CMV derived construct, S'cat3'. The DNA plasmid vector 
carried the 5'cat3' construct immediately downstream of the CaMV 35S promoter 
and was linearised at the 3' end of the viral sequence prior to inoculation onto 
CMV infected tobacco plants. RNA transcripts of the construct were made by 
utilising the T7 RNA polymerase promoter sequence fused to the 5' end of the 
5'cat3' construct. T7 run-offs were inoculated onto CMV infected tobacco plants 
and monitored for CAT expression. 
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MATERIALS AND METHODS. 
Construction of the DNA vector. 
The 5'cat3' segment of p5'cat3' was amplified using the 3vec3 primer and a modified 
5vec4 primer (Appendix I). The 5vec4c primer (5'-GTAATCTAACCACCTGTGTG-3'0H) 
lacks the Xhol site found in primer 5vec4: its first 5' nucleotide is the first base of the 
RNA 3 sequence. The resultant PCR product was blunt-end ligated into the Stu! site of 
pUC18-35S (Oessens & Lomonossof, 1993) as per appendix J. Clonal orientation was 
determined by restriction enzyme analysis. A clone carrying the 5'cat3' construct in the 
correct orientation was sequenced using the 5vec5 primer (Appendix 0). 
Construction of the 5'cat3' RNA constructs. 
A primer incorporating the T? RNA polymerase sequence, primer 5vec6b (5'-
A TTAA T ACGA CTCACTATAG TAATCTAACC ACC-3'0H) was used together with the 
3vec3 primer (Table 3.1) to amplify the vector construct from p5'cat3' (Appendix I). 
Repeated attempts at cloning this product proved futile; the resultant clones all lacked 
the T? promoter sequence. RNA transcripts were therefore made using the PCR product 
as template. Transcription was performed as per the Boehringer-Mannheim T? RNA 
polymerase protocol on two microlitres of PCR product. 5µ1 aliquots of run-off product 
were incubated with 2 units of ONase or 10µg of RNase respectively, incubated at 37°C 
for 30 minutes and run on RNase free 1 xTBE (Fig. 4.2) gels with untreated transcription 
products ( Appendix E). The gels were blotted onto Hybond N+ nylon membrane in 20x 
SSC as per the manufacturers instructions. Blots were probed in high SOS buffer 
(Appendix F) with digoxigenin labeled CAT probe (Appendix Gi) and detected using 
chemiluminescence as per the Boehringer-Mannheim protocol (Fig 4.2). A 2µ1 aliquot 
was taken from the correctly sized RNA band and used in a reverse transcription 
reaction (Appendix H) using primer 3vec3. Second strand synthesis was performed with 
the 5vec4 primer. The cDNA was amplified with the same primers and viewed on a 
1xTBE gel (Fig. 4.3), (Appendix E). Transcripts for inoculation were synthesised with the 
addition of an m7Gppp cap (Epicentre). 
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Inoculation of CMV Y RNA on plants. 
Nicotiana tabacum cv. xanthi seedlings at the 3-4 leaf stage were inoculated with total 
RNA extraced from a Nicotiana glutinosa plant systemically infected with CMV Y. RNA 
was isolated essentially following the method given by Verwoerd et al. ( 1989). Briefly; 2 
x 5g of leaf tissue was ground to a fine powder in liquid nitrogen and transferred to 2 
SOml centrifuge tubes. 12ml hot extraction buffer [phenol: 0, 1 M LiCl2, 1 OOmM Tris-HCI 
pH 8, 10 mM EDTA, 1% SOS (1:1)] was added to each tube and the sample vortexed. 
6ml chloroform was added to each tube and subsequently vortexed. After 30 minutes 
shaking at room temperature, the samples were centrifuged at 13000 rpm for 1 O minutes 
in a Sorval RC-5 Superspeed centrifuge. 15ml supernatant fluid was drawn off each 
sample and 7.5ml LiC12 was added per sample. The RNA was precipitated overnight at 
4°C and pelleted the following morning by centrifuging at 10000 rpm for 30 minutes at 
4°C. Pellets were resuspended in 5ml water and reprecipitated with 500µ1 3M ·sodium 
acetate, pH 4. 7 and 11 ml 100% ethanol. The samples were gently mixed and left at -
20°C for 4 hours. RNA was pelleted as before and resuspended in 1 ml water. All steps 
were taken to ensure that reagents and equipment were RNase-free. RNA was 
inoculated at a concentration of 250µg/ml in a 2% bentonite solution made up in 1xSTE, 
pH 6,8. A volume of 25µ1 was inoculated per leaf of the plant. Seedlings were 
systemically infected with CMV Y 8 days post infecton (p.i.) and were ready for vector 
inoculations. 
Vector Inoculations. 
The pUC18-35S plasmid containing the 5'cat3' construct in the correct orientation was 
linearised after the viral 3' sequence by utilising the Sacl site in the 3vec3 primer. This 
would generate an in vivo RNA transcript having 5 additional non-viral nucleotides at the 
3'-end. Linearised DNA was inoculated at a concentration of 133µg/ml (in a 2% 
bentonite solution made up in 1xSTE pH 6.8) onto three celite dusted leaves of Nicotiana 
tabacum cv xanthi plants that were all ready systemically infected with CMV Y. A total of 
1 Oµg of DNA was inoculated onto each plant. Circularised plasmid was inoculated 
similarly at a concentration of 266µg/ml or 20µg per plant. Plants were at the 8 leaf stage 
at the time of inoculation and the top three leaves of each plant were inoculated with the 
constructs. m 7 Gppp capped T7 transcripts were inoculated at a total concentration of 
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133µg/ml which meant that approximately 5µg of the correctly sized transcript was 
inoculated per plant. 
CAT ELISA analysis of inoculated plants. 
16 mm punches were taken from the inoculated leaves at 3 and 5 days post inoculation. 
Leaf discs were ground up in 400µ1 extraction buffer (0,25 Tris, pH 7.8, 5mM EDTA, 1% 
p-mercapto-ethanol ) and centrifuged at 4°C for 15 minutes. The supernatant flu id was 
drawn off and the protein concentration was determined by a standard Bradford assay 
(Appendix K). A volume representing 50µg of total protein was used in the Boehringer-
Mannheim CAT ELISA Detection Kit. A negative control plant leaf punch was spiked 
with 100 pg CAT enzyme to serve as a positive control, as no positive control CAT-
expressing plants were available .. 
Northern blot analysis of inoculated plants. 
400 mg of an inoculated leaf was ground up in liquid nitrogen and added to 1 ml of Trizol 
(life Sciences) reagent. Total RNA was extracted as per manufacturers instructions and 
run on an RNase free gel ( Fig. 4.4 & 4.5) as per Appendix E. Gels were run in 
duplicate, blotted and probed with either a DIG-labelled CAT RNA probe (Appendix Gii) 
or dig-labeled CMV RNA 3' RNA probe (Appendix Giii), (Fig 4.4 & 4.5). Detection was 
according to the Boehringer-Mannheim chemiluminescence detection protocol. 
RESULTS. 
CONSTRUCTION OF THE DNA VECTOR. 
The 5'cat3' construct could not be excised from p5'cat3' as the Xhol site situated 
on the 5'-end of the viral 5' sequence was repeated in the 5'-end of the 5vec5 
primer initially used to clone the 5' UTR. It was therefore necessary to amplify the 
fragment using a new 5' primer, 5vec4c, and the old 3vec3, and blunt clone it into 
the specially constructed Stu I site situated at the transcription init iation site of the 
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CaMV 35 S promoter found in pUC 18-35S (Fig 4.1.) (Dessens & Lomonossoff, 
1993). 
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Figure 4.2. Analysis of the vector transcripts. (A.) Lane 1: 8 µI of a transcription reaction 
including m7 Gppp capping reagent; lane 2: 8µ1 of a standard T7 RNA polymerase reaction from 
PCR product of the 5'cat3 construct bearing the T7 promoter sequence at its 5'-end and lane 4: 
ONA cut with Pst I (the sizes of the fragments are indicated in kb in the illustration). The expected 
1.2 RNA transcript is also indicated. (8.) Northern blot analysis of the transcripts using a OIG-
labelled DNA fragment specific for the CAT gene. Lane 1 :RNase treated transcripts; lane 3: 
Positive PCR control of the 1.2 kb S'cat3' fragment and lane 4: DNase treated transcripts. The size 
of the Gibco BRL RNA molecular weight marker is indicated alongside the autoradiograph in kb. 
(C.) Gel showing the relative sizes of A.-DNA cut with Pst I and RNA molecular weight marker from 
Gibco BRL on a 1% agarose gel. 
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Primer 5v4c was made to eliminate the Xho I site in primer 5vec4 and ensure that 
the viral sequence started at the start of the inserted sequence. Sequencing over 
the junction site confirmed that no extra non-viral nucleotides were inserted 
between the 5' end of the construct cDNA and the transcription initiation site of 
the promoter. 
CONSTRUCTION OF THE RNA TRANSCRIPTS. 
The 5'cat3' construct was amplified from p5'cat3' using a primer containing the T7 
RNA polymerase promoter sequence and the 3' primer, 3vec3. Several 
unsuccessful attempts were made at cloning the product into blunted vectors. On 
each of numerous occasions that a clone of the correct size and orientation was 
obtained, sequencing of the 5' end revealed that the T7 promoter sequence was 
missing. It was however possible to obtain RNA transcripts by using PCR product 
as template in a T7 RNA polymerase transcription reaction. Gel analysis of the 
products revealed two bands, one at the expected size of 1.2 kilobase pairs and 
another smaller product (Fig 4.2). DNase and RNase treatment of the resultant 
products indicated that the products were definitely RNA (Fig 4.2). Both of the 
run-offs contained the CAT gene as demonstrated by hybridisation to the CAT 
probe (Fig. 4.2). Reverse transcription of the products demonstrated that the 
larger product was indeed the correct sized RNA (Fig. 4.3). The smaller RNA 
could not be reverse transcribed by the primer complementary to the 3' -end of the 
construct. Once the integrity of the transcripts had been determined, transcripts 
were done in reaction mixes containing m7 Gp pp and lower concentrations of GTP 
to make capped RNA transcripts of the vector (Fig. 4.2). 
1.99-
1.70-
1.16-
1.09-
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Figure 4.3. Analysis of the reverse transcription and amplification of the larger T7 transcript 
generated from the PCR templates. Lane 1: DNA cut with Pst I (the sizes of the fragments are 
indicated in kilobasepairs); lanes 2 - 4: product of the reverse transcription/amplification of the 
transcript; lane 5; positive control amplification of p5'cat3' utilising the same primers as in the 
reverse transcription/amplification steps and lane 6: product from the reverse transcription and 
amplification of the smaller transcription product. 
CAT ELISA. DETECTION. 
No CAT protein was detected in any of the inoculated plants at 3 or 5 days post 
inoculation. There was no reduction in the activity of the enzyme used to spike a 
healthy leaf sample at the start of CAT isolation from the leaves. The ELISA 
could be used to quantify CAT when present in extracts at 100 pg/ml or 20 pg in 
50 µg of total protein (400 pg/mg protein). 
NORTHERN BLOT ANALYSIS OF THE INOCULATED PLANTS. 
No CAT RNA could be detected in total RNA extracts from leaves inoculated with 
either the DNA or RNA vector (Fig.4.4). 7,34 x 10"16 moles of the target sequence 
could be detected using the CAT RNA probe. Northern blot analysis of the 
inoculated leaves demonstrated replicating CMV as detected by a probe 
complementary to the 3' UTR of CMV Y RNA 3 (Fig. 4.5) . . This probe was able to 
detect down to 73,4 femtomoles of the target sequence.. . 
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Figure 4.4. Analysis of the production of chloramphenicol acetyl transferase 
(CAT) in inoculated plants. (A.) Total RNA isolated from inoculated and control plants; 10µg 
RNA was loaded per lane. Lanes :DNA molecular weight markers, A.-DNA cut with Pstl (the sizes 
of the fragments are indicated in kilobasepairs at the side of the photograph; see fig. 4.3 for a 
comparison of DNA and RNA molecular weight markers); lanes 2 & 3: RNA from CMV infected 
plants inoculated with the RNA vector transcripts; lane 4: RNA from CMV infected plants 
inoculated with the linearised DNA vector; lane 5: RNA from a CMV infected plant and lane 6: 
RNA from a healthy Nicotiana tabacum cv. Xanthi plant. Lanes 8-13 are Sacl linearised p5'cat3', 
size 4.1 kb, run as positive controls in increasing concentrations of 10 pg, 100pg, 1ng, 10ng, 
1 OOng and 200ng. The lower band is uncut plasmid (B.) Northern blot analysis of the same gel 
using the DIG-labeled RNA probe for negative sense CAT RNA. The sizes of the fragments of A.-
DNA cut with .Pst I are indicated alongside the photograph in kb. 
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Figure 4.5. Detection of CMV RNA in the inoculated plants. (A.) Total RNA isolated 
from inoculated and control plants; 1 Oµg RNA was loaded per lane but only 2µg was loaded in the 
CMV infected control plant lane. Lane 1 :ONA molecular weight markers, A.-ONA cut with Pstl (the 
sizes of the fragments are indicated in kilobasepairs at the side of the photograph; see fig. 4.3 for 
a comparison of ONA and RNA molecular weight markers); lane 2: RNA from a CMV infected 
plant inoculated with the RNA vector transcript; lane 4: RNA from a CMV infected plant 
inoculated with the linearised DNA vector; lane 5: RNA from a CMV infected plant and lane 6: 
RNA from a healthy Nicotiana tabacum cv. Xanthi plant. Lanes 8-13 are Sacl linearised p5'cat3', 
size 4.1 kb, run as positive controls in increasing concentrations of 1 O pg, 1 OOpg, 1 ng, 1 Ong, 
100ng and 200ng. The lower band is uncut plasmid (B.) Northern blot analysis of the same gel 
using the DIG-labeled RNA probe for negative sense CAT RNA. 
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DISCUSSION 
The expression of a foreign protein in a plant is a difficult task. A suitable assay 
system is essential to detect both the expressed protein and its RNA. Reliable 
positive controls are also required. The CAT ELISA results indicated that the 
CAT could have been produced at a level lower than 100 pg/ml of plant extract. 
This is 20 to 200 times lower than the 70 to 739 ng CAT/mg total protein obtained 
in transgenic plants carrying the cat-gene under the control of a CaMV 35S 
promoter (Gendloff et al., 1990). This level of expression would be of no use in 
the construction of a high level plant expression vector as too much plant material 
would have to be generated for large-scale protein extractions. A suitable 
positive control coufd have confirmed that the assay system was functional. CAT 
has been expressed in N. tabacum previously (Dawson et al., 1989; Gendloff et 
al., 1990) and is known not to be toxic to the plant. 
Northern blots indicated that no detectable cat RNA was being transcribed (Fig. 
4.4) despite the high sensitivity of the blot - as little as 734 fmol of the target 
sequence could be detected. This would seem to indicate that the problem of cat 
expression was at the level of replication of the vector and not due to a 
translational problem. 
As little as 7 fmol of CMV RNA could be detected on the total RNA extracts from 
CMV infected plants inoculated with the constructs as well as the CMV control 
plants (Fig. 4. 5). A fully functional, replicating vector would have shown up as a 
1.2 kb RNA band on the northern blot using the CMV 3'-end as a probe. No band 
was visualised at this size, even at shorter exposure times (not shown), 
suggesting that the vector was not replicating in the CMV infected plants. 
There are several possible reasons as to why the vector construct was not 
recognised by the viral replication machinery and amplified in the plant host. The 
first is that the 5' and/or 3' UTR's are not biologically active. This could be 
overcome by first isolating a full-length biologically active cDNA clone of CMV 
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RNA 3 and then excising the relevant control regions for further manipulations. 
Sequence analysis of the 5'- and 3'-untranslated regions did not however suggest 
that there were any serious deletions or insertions in the sequences other than 
the normal variations found amongst subgroup I CMV's, as shown in figures 3.5 
and 3.6. There did riot appear to be any major disruptions of the secondary 
structures of these control regions either, as demonstrated in figures 3.8 and 3.9. 
The other possible reason as to why the vector was not replicated could lie in the 
fact that the 5' and 3' regions are taken from CMV RNA 3, which in wild type 
viruses also carries a third.UTR in the intergenic region between the coat protein 
gene and the 3a movement protein gene (Fig 3.3). This region has been found to 
play an important role in the replication of BMV RNA 3. (Marsh et al., 1991 ). 
Deletion of sections of the internal control region of BMV decreased RNA 3 
replication in protoplasts to less than 15% of the wild type levels (Pogue et al., 
1992). Boccard and Baulcombe (1993) were able to demonstrate that mutants in 
the CMV RNA 3 of the Kin strain that resulted in truncated coat protein being 
produced, were still able to replicate to levels of 20% of the wild type virus. 
Mutants containing major deletions in the coat protein and in the intergenic region 
were unable to replicate at all. They were able to show that a 250-nucleotide 
region in the intergenic region was required for CMV RNA 3 accumulation ( 
Boccard and Baulcombe, 1993). Inclusion of the IGR of CMV Y RNA 3 into the 
vector construct as well as the insertion df a second reporter gene to approximate 
the size of CMV Y RNA3 may result in an effective, high level expression vector 
for the production of proteins in plants. 
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CONCLUSION 
The use of a viral expression vector for foreign protein production in plants is a 
relatively.. new and complicated concept. Although this attempt at constructing a 
viral expression vector from CMV RNA 3 proved unsuccessful it was not entirely 
fruitless. 
It would appear that without the IGR, the CMV RNA3 cannot be replicated, thus 
confirming the results of Boccard and Baulcombe (1993) that this region is 
essential for replication of the virus. This study has also shown that PCR can be 
used to amplify short control regions effectively. No unacceptable base pair 
changes occured in the 5' and 3' UTR's cloned in this project (Fig. 3.6 & 3. 7} and 
the secondary structures were maintained (Fig. 3.8 & 3.9). Conformation of the 
functionality of these regions would be to place the !GR of CMV-Y into the mini 
multiple cloning site of construct p5'cat3', downstream of the cat-gene (Fig. 3.5). 
A second reporter gene could be cloned between the inserted IGR and the 3'UTR. 
RNA transcripts could be generated as before and inoculated onto CMV-Y 
infected plants to test for expression of the reporter genes. The results of 
Boccard and Baulcombe ( 1993) would suggest that such a construct should be 
recognised by the viral replication machinery and replicated together with the viral 
genomic RNAs. 
In trying to repeat this endeavour, it would be advisable to obtain a full-length 
biologically active cDNA copy of the entire RNA3 molecule of the CMV Y genome. 
The 3a and coat protein genes could be excised and replaced by two reporter 
genes of similar coding capacities to try and maintain the original size of the wHd 
type RNA3. 
The discovery that completely denatured ds RNA of CMV Y is fully infectious is, 
as far as can be determined, a novel result. It has previously been thought that 
ds RNA of ss RNA viruses is non-infectious. This study demonstrated that ds 
RNA as such is non-infectious, but once it is denatured by heat and DMSO it is 
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infectious enough to cause symptoms in all the plants tested. A preparation of ds 
RNA thereofor represents a viable alternative for the long-term storage of ss RNA 
plant viruses, especially labile viruses such as CMV and AIMV. 
Tobacco plants containing the HPV-16 capsid protein gene have been made. 
Whether the L 1 gene exists in these 17 plants as an integrated insert or as an A. 
tumefaciens contaminant remains to be determined. Further studies need to be 
conducted on these plants at the DNA, RNA and protein levels to characterise the 
possible expression of the L 1 protein. 
In conclusion, the field of viral expression vectors is still growing rapidly, with new 
discoveries being made regularly. This project has illustrated the complexities of 
constructing a plant viral expression vector system, the functioning of which we 
know little. All knowledge obtained about the system, be it positive or negative, 
contributes to the eventual success of the goal: 
THE PRODUCTION OF PROTEINS IN PLANTS USING A VIRAL 
EXPRESSION VECTOR. 
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APPENDIX 
A: Bacterial media, antibiotics and bacterial strains: 
All bacterial cultures were grown in Luria-Bertani medium containing the relevant 
antibiotics as indicated in Sambrook et al. (1989). 
Unless otherwise stated, all DNA was transformed into and isolated from E. Coli 
Dh5a. 
Mini-prep DNA was isolated from 1 ml cultures grown up overnight in 2ml 
Eppendorf tubes at 37°C, shaking vigourously. Maxi-prep DNA was obtained from 
1 OOml cultures grown up in 250 ml flasks in a similar fashion. 
8: DNA isolation procedures: 
Maxi-prep DNA was isolated using the Nucleobond AX PC-Kit 100 (Machery-
- Nagel). Minipreps were processed as in Sambrook et al. (1989) but utilising 
solutions 1, 2 and 3 as made in the Nucleobond kit. Miniprep DNA was · 
resuspended in 40 µI TE buffer and 5 µI was routinely in a restriction enzyme 
digest. 
C: Restriction enzyme analysis of DNA: 
DNA was routinely digested by the required enzyme under the conditions stated 
by the supplier (Boehringer-Mannheim). Two units of enzyme was used per 
microgram of DNA and digested for 1,5 hours at the recommended temperature. 
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D: Sequencing of cloned DNA templates: 
DNA was sequenced according to the protocol of the TaqTrack sequencing 
system of Promega. The forward sequencing primer was the 24mer primer #1212 
with sequence 5'-CGCCAGGGTTTCCCAGTCACGAC-3' while the reverse primer 
was the 24mer #1233 with sequence 5'-GAGCGGATAATTTCACACAGG-3'. 
The junction site of the DNA vector was sequenced using the 5vev5 primer used 
for PCR at a concentration of 20ng/µI. 
Sequence analysis was performed on the University of Wisconsin GCG package. 
Sequence comparisons were done on the ClustalW analysis program. 
E: Gel electrophoresis of RNA and DNA: 
The initial RT-PCR products of the 5'- and 3'-UTRs were run on 3% agarose gels 
in 1 xTBE. All other agarose gel electrophoresis was done in 1% agarose gels in 
1xTBE as indicated in Sambrook et al. (1989). Gels contained ethidium bromide . 
at a concentration of 0,5 µg/ml. 
RNA gels were run similarly except that the electrophoresis aparatus was soaked 
in 2% H20 2 overnight and rinsed thoroughly in DEPC-treated water and that all 
the reagents were prepared RNase free. 
DNA was sized against A.-DNA digested with Pstl to give 29 fragments-ranging 
from 15 bp to 11497 bp: 15, 72, 87, 94, 150, 164, 200, 211, 216, 247, 264, 339, 
448, 468, 514, 805, 1093, 1159, 1700, 1986, 2140, 2443, 2459, 2560, 2838, 
4507, 4749, 5077 and 11497 bp. 
RNA was sized against the RNA molecular weight marker I of Boehringer-
Mannheim. 
I 
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F: Hybridisation and detection of DNA/RNA blots: 
DNA gels were first denatured and then neutralised indicated in the Hybond N+ 
manual. Both DNA and RNA gels were blotted in 20xSSC; overnight for DNA gels 
and 6 hours for RNA gels. The nucleic acids were fixed to the membranes by 
exposing them, through clingwrap, to UV light for 3 minutes, nucleic acid side 
down. The membranes· were then rinsed in 2xSSC before preceding to the 
hybridisation step. 
DNA blots were prehybridised in the standard DNA prehybridisation buffer as 
given in the DIG System User's guide of Boehringer-Mannheim. Denatured DIG-
labelled DNA probe was added to the prehybridisation buffer at a concentration 
of 25ng/ml.. Membranes were incubated overnight at 68°C and washed the next 
day as per the DIG protocol. The hybridised probe was detected using the CSPD 
chemiluminescence detection system of Boehringer-Mannheim. 
RNA blots were treated similarly except that the blots were probed with DIG-
labelled RNA probes in high percentage SOS prehybridisation buffer containing 
50% formamide (DIG systems user's guide). Probe was denatured at 60°C for 10 
minutes and added to the prehybridisation buffer at a concentration of 30ng/ml. 
The lower probe concentration appeared to reduce the background signal. Blots 
were incubated at 68°C overnight and treated in the same manner as the DNA 
blots the following day. 
G: Probe preparation: 
i) CAT DNA probe 
A DIG-labelled DNA fragment of chloramphenicol acetyl transferase (CAT) gene 
was obtained by PCR labelling using the PCR DIG Probe Synthesis Kit 
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'(Boehringer-Mannheim). The CAT sequence specific primers were 18mers 
designed by K. E. Palmer and gave a 400 base pair product. 1 OOng of plasmid 
pCm1 (D. Rawlings) was used in a PCR DIG-labelling reaction using the following 
cycles: 3 minutes at 92°C, 30 seconds at 50°C and 1 minute at 72°C. 
ii) CAT RNA probe 
DIG-labelled RNA probes were obtained usng the DIG RNA labelling Kit 
(Boehringer"'.Mannheim) except that T3 RNA polymerase (Boehringer-Mannheim) 
and its 1 Ox buffer were used in the reaction mix. 
The positive sense CAT RNA probe was synthesised from Xhol linearised pCAT 
using T3 RNA polymerase. pCAT was synthesised by inserting the Taql fragment 
of the CAT gene into the Clal site of pBluescript SK. This probe would bind 
negative sense, replicating CAT RNAs. 
· iii) CMV RNA 3 3'UTR probe 
The negative sense DIG-labelled probe for the 3' UTR was made as a T3 RNA 
polymerase run-off from Pstl linearised pCMV3'. This probe would bind genomic 
or messenger sense viral RNA . 
H: Reverse transcription reaction: 
i) RNA denaturation. 
2µ1 RNA template ( about 1.5 ~Lg of ds RNA) was mixed with 2µ1 H20, 5µ1 DMSO 
and 1 µI RNase inhibitor (Boehringer-Mannheim), heated at 65°C for 10 minutes 
and placed on ice. 
ii) Reverse transcription. 
The 1 OµI denatured RNA solution was added to 40µ1 of reverse transcription 
reaction mix containing the following: 10 mM Tris-HCL at pH 8.9, 90 mM KCI, 
200µM of each dNTP, 0,9 mM MnC'2, 0,5µM of each primer and 4U Tth DNA 
polymerase (Boehringer-Mannheim). The volume was made up to 50µ1 with H20. 
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The reaction was performed at 70°C for 30 minutes after which EGTA was added 
to a concentration of 0, 75 mM. 
Primers 3vec3b and 3vec4 (table 3.1) were used to reverse transcribe th~ 3' UTR 
of CMV Noel green pepper while primers 5vec4 and 5vec5 were used for the 5' 
UTR 
2µ1 of the T7 RNA transcription product was pierced from both the upper and 
lower bands in an agarose gel and used for reverse transcription. Only the 
3vec3b primer was used to prime the reaction. 
I: Polymerase chain reaction (PCR): 
5µ1 of the reverse transcription reaction was used in a 100µ1 PCR reaction. The 
conditions were: 0,5 µM of each primer, 1.5mM MgCb, 200µM of each dNTP, 1 
unit Taq DNA polymerase (Advanced Biotechnologies) using the 1 Ox buffer 
supplied (200mM (NH4)2S04, 750 mM Tris-HCI pH 9.0 & 0,.1 % (w/v) Tween). All 
the primers used in this project were used under the following cycling conditions: 
94°C for 2 minutes for initial denaturation of the template; 25 cycles of 93°C for 1 
minute, 48°C for 30 seconds and 72°C for 90 seconds followed by a final round of 
72°C for 3 minutes. 
J: Blunt-end cloning of PCR products : 
i) Vector preparation. , 
5µg of vector DNA was typically digested with the required blunt end cutter 
enzyme for 1,5 hours, after which it was run on an agarose gel to check for 
complete digestion. Cut DNA was then extracted with phenol:chloroform to 
remove the enzyme. The DNA was precipitated with 0,5 vol. 5.25M ammonium 
acetate and 2 vol. 100% ethanol, mixed gently and left at -70°C for 30 minutes. 
DNA was recoverd by centrifugation in a benchtop centrifuge at 4°C for 15 
minutes and resuspended in H20 to a concentration of 1 OOng/µI. The digested 
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DNA was incubated with 24 units· calf intestinal phosphatase (CIP) for 30 minutes 
at 37°C to remove the 5' phosphate groups at the cut ends of the vector. The 
reaction was spiked with another 24 units of CIP enzyme and incubated a further 
15 minutes at 45°C. CIP was_ inactivated by heating at 70°C for 10 minutes. An 
equal volume of TE buffer was added to the mixture before being extracted once 
with phenol:chloroform. The DNA was precipitated as before and resuspended 
inTE buffer to a concentration of 1 OOng/µI. 
ii) Preparation of the insert. 
An equal volume of chloroform was added to the PCR reaction, vortexed and 
centrifuged 3 minutes. The aqueous phase was transfered to a new 1.5 ml tube 
and boiled for 10 minutes to destroy any residual taq DNA polymerase. The 
reaction mix was allowed to slowly cool down to room temperature. The PCR 
products were treated with polynucleotide kinase (PNK) to add phosphate groups 
to their 5'-ends. The reaction conditions were: 50mM Tris-HCI (pH 7,6), 10 mM 
MgCb, 10 mM ~-mercaptoethanol, 2mM ATP and 2 Units PNK (Amersham). The 
reaction was incubated at 37°C for 30 minutes, spiked with an equal volume of 
ATP and incubated for a further 30 minutes at 37°C. The PNK was inactivated at 
70°C for 10 minutes. The magnesil.~m concentration was adjusted to 5mM, dNTPs 
were added to 1 OO~LM and 2 units Kienow was added to the reaction. Incubation 
at room temperature (22°C) resulted in the PCR products being completely 
blunted. The insert was treated once with phenol:chloroform, the DNA being 
precipitated from the aqueous phase with 0,5 vol. ammonium acetate and 2 vol. 
100% ethanol. After precipitation at room temperature for an hour, the DNA was 
pelleted at 4°C for 15 ·minutes. The pellet was washed witn 70% ethanol and 
resuspended to give a concentration of approximaetely 1 OOng/µI. 
iii) Ligations. 
Ligations were routinely performed in 20µ1 with 2 units T4 DNA ligase · 
(Boehringer-Mannheim) at 15°C overnight. The vector:insert ratio for small PCR 
products of less that 500 base pairs was 1 :6 with the DNA concentration not 
exceding 800ng. The ratio for larger inserts was 1 :3 under similar conditions. 
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iv) Transformations. 
E. Coli cells were made competent for transformation using the rubidium chloride 
protocol of Chung & Miller (1988). 5µ1 of the ligation mix was routinely 
transformed into competant E. Coli Dh5a. Cells were plated onto agar plates 
containing the necessary antibiotics and incubated overnight at 37°C. 
Transformants were screened for inserts by digesting mini-prep DNA as indicated 
above. 
K: Bradford assay to determine protein concentration: 
i) Preparation of Bradford reagent: 1 OOmg of Coomassie Blue G-250 was 
-dissolved in 50 ml 95% ethanol (v/v). 100 ml of 85% phosphoric acid (w/v) was 
added and the volume adjusted to one litre with distilled water. 
ii) Protein determination: 5~d of total protein extract was added to 95 µI water and 
then added to 900 µI Bradford reagent. The solution was gently mixed to avoid 
bubble formation and the absorbance of the sample was read at 595 nm. The 
measurements were done between 5 and 45 minutes after the addition of the 
Bradford reagent to the sample. The protein concentration was calculated by 
comparing the absorbance of the sample with a calibration curve of BSA ranging 
from 10-100 µg/ml. 
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